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FoxA forkhead are conserved transcription factors that function in 
regulating foregut development of animals. FoxA factors regulate organogenesis 
from early cell fate specification to cell differentiation and functional 
morphogenesis by orchestrating timely transcriptional programs that drive these 
events at each developmental stage. Using the PHA-4/FoxA-dependent pharynx 
development in C. elegans as a model, we revealed that PHA-4 modulates 
temporal pharyngeal gene expression partly through DNA binding affinity. 
Pharyngeal genes with high affinity PHA-4 binding sites are competent to 
activate earlier when compared to genes with low affinity sites. We further 
demonstrated that affinity affects the level of PHA-4 occupancy at pharyngeal 
promoters and the decompaction of chromatin induced after PHA-4 binding. We 
tested the effect of affinity in response to changes in PHA-4 level and showed 
that temporal pharyngeal gene expression was sensitive to PHA-4 levels but was 
maintained properly within a range of PHA-4 level fluctuation. The dynamic level 
of PHA-4 during embryogenesis coordinates with the different binding affinity 
between PHA-4 and its targets to mediate the proper temporal order of 
pharyngeal gene expression. 
 Sequence-specific transcription factors are involved in regulating gene 
expression by recruiting RNA Pol II and/or mediating the release of paused RNA 
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Pol II at target genes. Poised Pol II at developmental regulated genes is shown 
to play an important role in controlling gene expression during embryogenesis in 
different organisms. However, poised Pol II is relatively rare in C. elegans. By 
examining the dynamic genome-wide Pol II occupancy at different embryonic 
stages, we discovered that poised Pol II was temporally regulated at different 
genes. Among poised pharyngeal genes, Pol II is found at genes that are either 
activated at later stages or highly expressed at earlier stages with a reduction in 
expression later. This result suggests that poised Pol II serves as a preparation 
for future gene expression or as a memory of past gene expression. Moreover, 
we showed that PHA-4 activity was required to load Pol II at poised pharyngeal 
genes. We propose that PHA-4/FoxA functions as a pioneer factor that primes 
gene activation by regulating Pol II.       
In summary, PHA-4 utilizes DNA binding affinity by differentially binding its 
targets to control the timing of activation. The binding of PHA-4 also regulates 
Pol II occupancy at pharyngeal promoters. Our studies delineate the role of PHA-
4 in regulating temporal gene expression during pharynx development and 
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1.1 Overview 
    Developmental processes, such as body axis patterning and organ 
formation, are driven by successive tiers of differential gene expression to 
regulate cell fate determination and cell differentiation. These events are often 
controlled by selector genes, which encode a special class of transcription 
factors functioning to control gene expression required for specifying cell, tissue, 
organ, and regional identity of animals (Mann and Carroll, 2002). The classic 
examples of selector genes are the Hox genes, which regulate the specification 
of body segments along anterior-posterior axes in many organisms. As Antonio 
Garcia-Bellido proposed, Hox genes regulate a cohort of downstream genes, 
also called realisators or effectors, which confer specific properties to cells 
involving cell division, cell adhesion, cell migration, and apoptosis to coordinate 
morphogenesis of body segments (Garcia-Bellido, 1975; Hueber and Lohmann, 
2008). 
 Based on the features of selector genes, the loss of activity of selector 
genes often leads to the perturbation of the selector-regulated transcriptome and 
results in the loss of specific functional structures. An example manifested in C. 
elegans is pharynx development. The C. elegans pharynx is a pumping and 
feeding organ that consists of neurons, glands, structural cells, epithelia, valves 
and muscles. In forkhead transcription factor pha-4/foxa null mutants, C. elegans 
embryos completely fail to form a pharynx (Horner et al., 1998; Kalb et al., 1998; 
Mango et al., 1994). Conversely, ectopic PHA-4 expression throughout the 
embryo generates extra pharyngeal cells (Horner et al., 1998). Using a 
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temperature-sensitive mutant to investigate the effect of reducing PHA-4 activity 
at different developmental stages revealed that PHA-4 activity is essential for 
viability throughout life. Eliminating PHA-4 activity at early embryonic stages 
causes 100% lethality and no pharynx specification (Kiefer et al., 2007; Mango et 
al., 1994). Abrogating PHA-4 expression at later stages results in different 
degrees of pharyngeal defects, such as Pharynx unattached (Pun) and a stuffed 
pharynx (defects in pharyngeal pumping) phenotypes (Gaudet and Mango, 2002; 
Kiefer et al., 2007). These results indicate that PHA-4 is a master regulator and 
continuously required to regulate a comprehensive pharyngeal gene expression 
and form a functional pharynx during embryogenesis.  
 To ensure a reliable and reproducible developmental program, differential 
gene expression must be precisely regulated in a spatial and temporal manner, 
and proper gene expression levels must be maintained. A key question is how 
selector genes regulate the differential expression of multiple targets required for 
distinct developmental processes at specific stages. Selector genes often 
regulate differential gene expression through multiple strategies.  For example, 
selector genes can function in a hierarchical manner as development proceeds 
by activating several genes at the top of a cascade. These targets directly 
activated by selectors will further carry out the effect of selectors through 
regulation of downstream genes (effectors) in the cascade. One example of 
hierarchical regulation is intestinal development in C. elegans. C. elegans GATA-
type transcription factors end-1 and end-3 are essential for endoderm cell fate 
specification and activate a second set of GATA factors, ELT-2, ELT-4, and ELT-
	   4	  
7 (McGhee et al., 2007). ELT-2 and ELT-7 directly control the intestinal effector 
genes encoding the functional and structural proteins (McGhee et al., 2009; 
McGhee et al., 2007; Sommermann et al., 2010).  
 Other selector genes can directly bind multiple targets but regulate their 
expression differentially during development. For example, MyoD, a bHLH 
transcription factor belonging to the family of myogenic regulatory factors, 
globally regulates the transcriptome required for skeletal muscle development 
(Cao et al., 2010; Tapscott et al., 1988). MyoD directly regulates its targets by 
forming heterodimers with E-proteins (E12, E47, and HEB) and binding to the 
cis-element E-boxes (Puri and Sartorelli, 2000). MyoD controls the timing of 
target gene expression through feed-forward circuits and cooperative binding 
with co-factors, such as AP-1, Meis, Runx, and Sp1, to activate muscle-specific 
genes (Biesiada et al., 1999; Knoepfler et al., 1999; Sartorelli et al., 1990). MyoD 
also activates the expression of the transcriptional repressor RP58, which 
represses Inhibitor of DNA binding (Id) proteins in early differentiated muscle 
cells. Id2/Id3 are negative regulators of myogenesis that compete with MyoD to 
heterodimerize with E-proteins and therefore attenuate MyoD function. RP58 
represses the expression of Id2/Id3 to make E-proteins available and thereby 
allows MyoD to activate the late differentiation genes (Benezra et al., 1990; 
Yokoyama et al., 2009). In summary, MyoD binds to various myogenic promoters 
and is sufficient to activate early myogenic genes but not late genes. On late 
genes, MyoD binding induces histone acetylation to facilitate binding of co-
factors and other transcription factors, such as Myog and Pbx, to activate gene 
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expression (Cao et al., 2006). The time delay in the sequential recruitment of 
factors at MyoD late-stage targets assures the temporal expression patterns of 
late myogenic genes.     
Functioning as a selector gene, PHA-4/FoxA broadly binds to the cis-
element TRTTKRY (R= A/G, K= T/G, Y= T/C)	   within pharyngeal targets (and 
elsewhere in the genome) and activates their expression at different stages and 
in different pharyngeal cell types (Gaudet and Mango, 2002; Mango et al., 1994). 
Similar to MyoD, PHA-4 also regulates temporal pharyngeal gene expression 
through a feed-forward circuit. An example is the expression of pharyngeal 
muscle myosin, myo-2, which is activated by PHA-4 and a homeobox 
transcription factor, CEH-22 (Kalb et al., 1998; Okkema and Fire, 1994). PHA-4 
initiates the expression of ceh-22 in pharyngeal muscles during mid-
embryogenesis (Mango et al., 1994; Vilimas et al., 2004). Both PHA-4 and CEH-
22 bind to the myo-2 promoter and activate myo-2 expression at later embryonic 
stages (Ao et al., 2004; Gaudet and Mango, 2002; Zhong et al., 2010). 
Combinatorial regulation via feed-forward circuits is a common mechanism 
employed by selector genes to control differential gene expression. 
Distinct from MyoD, PHA-4 also utilizes binding site affinity to control the 
onset of gene expression. It has been shown that PHA-4 binds to different 
TRTTKRY sequences found at endogenous targets with differential affinity 
(Gaudet and Mango, 2002). Furthermore, PHA-4 binding affinity modulates the 
temporal expression of pharyngeal genes. Changing a PHA-4 binding site to 
increase or decrease the binding affinity within the promoter context resulted in 
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advanced or delayed pharyngeal gene expression (Gaudet and Mango, 2002). 
This result indicates that PHA-4 binding site affinity is a critical determinant of 
temporal pharyngeal gene expression. In this chapter, I will discuss that PHA-
4/FoxA, as a model selector gene, orchestrates temporal gene expression to 
govern pharynx development. A proposed model of PHA-4/FoxA-regulated 
temporal pharyngeal gene expression will be described in detail. The connection 
and a potential role of PHA-4/FoxA in regulating RNA Polymerase II will be 
discussed as well.  
 
1.2 Temporal control of pharyngeal organogenesis  
by PHA-4/FoxA 
1.2.1 Pharynx development in C. elegans and PHA-4 expression 
 To form a pharynx, C. elegans early embryos first generate a group of 
pharyngeal precursor cells derived from two cell lineages, EMS and AB (2 
blastomeres in the 4-cell embryo).  The number of pharyngeal precursors is 
increased during gastrulation. At mid-embryogenesis, the pharyngeal precursors 
assemble and form the pharyngeal primordium. The pharyngeal precursors 
subsequently specify six different pharyngeal cell types, including pharyngeal 
muscle, gland, valve, epithelial, neural, and structural cells. Morphogenesis and 
terminal differentiation of the different pharyngeal cell types further establish a 
functional pharynx (Figure 1.1) (Mango, 2009).  
 
 









A cartoon of PHA-4 expression and pharynx development during 
embryogenesis. PHA-4 is activated from the 2E stage in the pharyngeal 
precursors. At early embryonic stages, the pharyngeal precursors divide during 
gastrulation. The pharyngeal primordium is formed and pharyngeal cell types are 
subsequently specified during mid-embryogenesis when embryonic cell division 
is completed. A functional pharynx is formed after cell differentiation and 
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Prior to gastrulation, maternally contributed Notch signaling initiates two 
separate cascades to activate pha-4 expression in the pharyngeal precursors 
derived from EMS and AB descendants  (Mango et al., 1994; Priess et al., 1987).  
PHA-4 is the earliest marker of pharyngeal expression. PHA-4 is activated in all 
pharyngeal cells during early gastrulation, at the 2E stage (the stage when 
embryos contain two endodermal cells, in total ~28 cells in the embryo), and 
maintained throughout life (Mango, 2009). PHA-4 expression is increased during 
embryogenesis and reaches its maximum level during mid-embryogenesis 
(Horner et al., 1998; Smith and Mango, 2007). PHA-4 is also expressed in midgut 
and hindgut, but its function in these tissues is not well characterized (Azzaria et 
al., 1996; Horner et al., 1998; Updike and Mango, 2007). In larvae, PHA-4 is 
expressed in the somatic gonad, where it is important for its formation (Azzaria et 
al., 1996; Updike and Mango, 2007). 
 
1.2.2 PHA-4 is an organ selector gene for pharynx development 
 PHA-4 is the central regulator of pharynx development and pha-4 null 
alleles delete virtually the entire pharynx (Mango et al., 1994). This dramatic 
phenotype reveals that PHA-4 is an organ selector gene for foregut formation in 
worms, and its activity is globally required for all pharyngeal expression, including 
early developmental regulators that help specify pharyngeal cell types, as well as 
late differentiation genes encoding structural proteins and enzymes. Therefore, 
losing PHA-4 activity at different embryonic stages results in a wide spectrum of 
pharyngeal phenotypes. Eliminating PHA-4 expression at early embryonic stages 
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causes embryonic lethality, and nascent pharyngeal cells are transformed to 
other cell fates. Withdrawing PHA-4 activity at later stages leads to different 
degrees of pharyngeal functional defects such as irregular pharyngeal pumping 
and misplaced cells (Gaudet and Mango, 2002; Kaltenbach et al., 2005; Kiefer et 
al., 2007; Mango et al., 1994). 
How PHA-4/FoxA modulates transcription to control pharynx development 
is one of the key questions for understanding the function of selector genes. One 
possibility is that PHA-4 regulates transcription by altering the chromatin 
environment. Studies of PHA-4 mammalian orthologs, the FoxA factors, 
demonstrate that FoxA transcription factors function as pioneer factors (Cirillo et 
al., 2002; Lupien et al., 2008). Pioneer factors initiate binding to targets prior to 
transcription, before other factors can access DNA. The binding of pioneer 
factors induces an open chromatin conformation that allows other factors to bind 
(Zaret and Carroll, 2011). In the initial model, FoxA blocked H1 histones, leading 
to local decompaction (Zaret and Carroll, 2011), but more recent studies have 
suggested FoxA binding leads to loss or destabilization of a nucleosome (Li et 
al., 2012). On the other hand, FoxA factors in mammals and Fkh factors in yeast 
can have long-range effects that promote transcription factors loading or 
recombination (Lupien et al., 2008; Sun et al., 2002). In C. elegans pharyngeal 
nuclei, PHA-4 bound to extrachromosomal arrays carrying PHA-4 targets prior to 
pharyngeal transcription and resulted in broad chromatin decompaction of the 
arrays (Fakhouri et al., 2010). The chromatin decompaction induced by PHA-4 
activity is partly accomplished through recruitment of the histone variant HTZ-
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1/H2A.Z to a subset of pharyngeal promoters (Updike and Mango, 2006). 
Genome-wide studies in various organisms indicate that H2A.Z containing 
nucleosomes flanked around transcription start sites (Barski et al., 2007; Luk et 
al., 2010). The presence of HTZ-1/H2A.Z also correlates with the occupancy of 
RNA Pol II, but not with actual transcription (Whittle et al., 2008). These 
observations suggest that PHA-4 might prime pharyngeal expression by affecting 
the chromatin environment and facilitating recruitment of downstream factors. 
 
1.2.3 PHA-4 regulates temporal pharyngeal gene expression  
 Recent genome-wide chromatin immunoprecipitation-sequening (ChIP-
Seq) studies have shown that PHA-4 binds more than 5000 genomic regions in 
mixed-stage embryos (Zhong et al., 2010). 90% of PHA-4 binding sites were 
assigned to protein coding genes that gave rise to approximately 4000 PHA-4 
direct targets, including the previously identified PHA-4 targets (Ao et al., 2004; 
Gaudet and Mango, 2002; Gaudet et al., 2004). RNA-Seq further confirmed that 
87% of PHA-4 targets were actively expressed in embryos. These results 
indicate that PHA-4 directly binds its targets to broadly activate gene expression 
during embryogenesis. 
Previous studies revealed that PHA-4 alone functions as a weaker 
transcriptional activator by which three PHA-4 binding sites activated weak and 
patchy pharyngeal expression of a green fluoresce protein (GFP) reporter 
(Gaudet et al., 2004). The combination of PHA-4 sites with additional cis-
regulatory elements supported more stable and specific pharyngeal gene 
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expression either in the whole pharynx or in specific pharyngeal cell types 
(Gaudet et al., 2004; Okkema and Fire, 1994; Raharjo and Gaudet, 2007). 
Conversely, pharyngeal cis-regulatory regions without PHA-4 sites failed to 
activate pharyngeal expression of GFP reporters (Gaudet and Mango, 2002; 
Raharjo et al., 2010). This result indicates that PHA-4 is required but is not 
sufficient to support robust pharyngeal gene expression.  
A fundamental question is how PHA-4 differentially regulates its targets 
that function in various processes of pharynx development. The features of PHA-
4 acting as a pioneer factor and the necessity of PHA-4 binding sites in 
modulating pharyngeal activation indicate that the interaction of PHA-4 with its 
target DNA is the primary determinant of pharyngeal expression. Indeed, the 
binding affinity between PHA-4 and its target promoters is a key input to regulate 
proper temporal pharyngeal gene expression. Previous studies from the Mango 
lab showed that pharyngeal promoters containing high affinity PHA-4 binding 
sites tend to activate earlier in development compared to promoters with low 
affinity PHA-4 sites (Gaudet and Mango, 2002). More importantly, the presence 
of a point mutation to change PHA-4 binding affinity within the promoter shifted 
the timing of pharyngeal activation—higher affinity activated expression earlier 
whereas lower affinity led to later onset (Gaudet and Mango, 2002). The 
mutations did not alter the strength of expression but only the onset of timing. 
These results reveal how the regulatory information embedded in the genome 
plays a role in setting up differential gene expression.  
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PHA-4 binding site affinity cannot fully account for all temporal pharyngeal 
gene expression. One example is the expression of pharyngeal muscle myosin, 
myo-2, which contains high affinity PHA-4 binding sites but is not activated until 
late embryogenesis. As mentioned previously, detailed promoter assays revealed 
that both PHA-4 and CEH-22 are required to activate myo-2 (Gaudet and Mango, 
2002; Mango et al., 1994; Okkema et al., 1997). These studies indicate a feed-
forward mechanism of myo-2 expression in which PHA-4 first activates ceh-22 at 
mid embryogenesis, and then works combinatorily with CEH-22 at the myo-2 
promoter, to activate myo-2 at later stages. The combination of binding site 
affinity and other factors in controlling precise pharyngeal gene transcription 
motivated us to search for other potential factors and cis-elements that might 
work with PHA-4 to refine the patterns of pharyngeal gene expression.  
To identify the regulatory elements that function together with PHA-4 to 
mediate temporal pharyngeal gene expression, pharyngeal specific targets were 
grouped based on the timing of their onset (early versus late pharyngeal genes). 
Bioinformatic analyses were conducted to search for overrepresented motifs 
specifically in early or late pharyngeal targets, termed early or late elements 
(Gaudet et al., 2004). Moreover, synthetic promoters confirmed that these 
identified temporal elements functioned as pharyngeal enhancers and 
contributed to temporal control of pharyngeal expression (Gaudet et al., 2004). 
These temporal motifs, including GAGA rich sequences, were highly enriched in 
genome-wide PHA-4 binding targets identified from ChIP-Seq (Zhong et al., 
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2010). These data provide a framework for understanding the logic of temporal 
control of pharyngeal gene expression. 
Based on previous studies, we proposed a model for PHA-4-controlled 
temporal pharyngeal gene expression in which PHA-4 binds to sites with different 
affinity and functions in combination with factors associated with “early elements” 
or “late elements” to fine-tune the onset of pharyngeal gene expression (Figure 
1.2). In the proposed model, PHA-4 affinity binding sites are differentially bound 
by PHA-4 as PHA-4  expression levels  change  during  embryogenesis.  PHA-4 
binds to high affinity sites efficiently to initiate gene expression when the PHA-4 
level is low at early embryonic stages. Low affinity targets are not bound stably to 
activate transcription until the PHA-4 level is increased later in development. In 
addition, other transcription factors express at different embryonic stages and 
bind to early or late elements at pharyngeal promoters/enhancers. The 
availability of both inputs from PHA-4 and secondary factors determines the 
proper pharyngeal expression patterns. In summary, high affinity PHA-4 sites 
and early elements promote early onset of pharyngeal expression in contrast to 
low affinity PHA-4 sites and late elements, which delay gene activation. The 
matching of PHA-4 affinity sites and different temporal elements at individual 
pharyngeal promoters/enhancers controls the precise timing of pharyngeal 
activation. 
The proposed PHA-4 affinity model would predict that pharyngeal gene 
expression is sensitive to PHA-4 levels. Increased PHA-4 expression might 
saturate  the  PHA-4  binding  sites  and  advance  the  onset of pharyngeal gene  
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Figure 1.2  
A model for temporal control of pharyngeal gene expression in C. elegans. 
Four transcription factors including PHA-4 are differentially expressed during 
embryogenesis. Gene A, B, C, and D are four pharyngeal genes express from 
different stages. In this model, both PHA-4 and other factors are required for 
proper pharyngeal expression. During early embryonic stages, PHA-4 level is low 
and only high affinity PHA-4 sites (Gene A and B) bound by PHA-4 are efficient 
for activating expression in comparison to low affinity PHA-4 sites (Gene C and 
D). Other transcription factors, which could be an activator or a repressor (white 
and gray circle and light gray hexagon), associate with early and late elements at 
different stages depend on their availability and levels. The onset of pharyngeal 
expression is determined by the combinatorial inputs from both PHA-4 and other 
transcription factors. Gene A, which contains a high affinity PHA-4 site, and an 
early element is activated by earliest time point by PHA-4 and the early factor. 
The delayed recruitment of late factors associated with late elements retards the 
timing of expression. The precise timing of pharyngeal expression is fine tuned 
by the match of different PHA-4 affinity sites and temporal elements (Adopted 
from Banerjee and Slack, 2005). 	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expression. This assumption predicts that temporal patterns of pharyngeal 
expression could be  maintained  within  a  range  of  PHA-4  levels  in which  the 
difference of PHA-4 binding to various affinity sites still translates to the 
differential timing in activation of gene expression. In other words, dramatic 
fluctuation  of  PHA-4  levels  beyond  the tolerance of binding affinity will result in 
misregulation of pharyngeal gene expression. We later tested this idea of affinity- 
controlled differential gene expression, which is discussed in Chapter 2.  
 
1.3  RNA Polymerase II pausing and differential  
gene regulation 
 How do selector genes regulate gene expression after binding to their 
targets? The major target in controlling transcription of protein-coding genes is 
RNA Pol II. The transcriptional cycle of RNA Polymerase II contains at least 3 
different phases: (1) initiation, where Pol II is recruited along with general 
transcription factors (GTFs) to form the preinitiation complex (PIC) at a promoter 
and starts to synthesize short RNA transcripts, (2) elongation, when Pol II 
escapes from the initiation site and moves into gene bodies to produce RNA, and 
(3) termination, in which Pol II and RNA transcripts disassociate from the DNA 
when transcription is completed (Adelman and Lis, 2012; Gilchrist and Adelman, 
2012). It was long thought that sequence-specific transcription factors control 
gene expression mainly at the transcription initiation step by recruiting the 
transcription machinery to specific loci. Certain unusual cases were known, such 
as the Drosophila heat shock gene, in which heat shock factor (HSF) regulated 
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the release of promoter proximal paused Pol II at hsp70 upon heat shock 
stimulus (O'Brien and Born, 1991). However, Pol II pausing was thought to be 
rare. Recent genome-wide studies of Pol II occupancy have revealed widespread 
Pol II pausing at promoter proximal regions in Drosophila, mouse, and human 
cells (Core et al., 2008; Muse et al., 2007; Nechaev et al., 2010; Rahl et al., 
2010; Zeitlinger et al., 2007). These results suggest another layer of gene 
expression regulation postinitiation of RNA Pol II. In Chapter 3, I examined Pol II 
occupancy and PHA-4 in C. elegans. Below I summarize what is known about 
paused Pol II.  
 
1.3.1 Discovery of Pol II pausing at promoter proximal regions 
Depending on the cell type and organism, it has been shown that 10–60% 
of genes exhibit 5’ enriched Pol II signals at promoter proximal regions (Core et 
al., 2012; Nechaev et al., 2010; Zeitlinger et al., 2007). Further studies showed 
that the 5’ enriched Pol II is transcriptionally engaged, with phosphorylation of 
Ser5 with the Pol II carboxyl-terminal domain repeat (CTD), but pauses 
downstream of the transcriptional start site after generating 30 to 50-nucleotide 
long RNA transcripts (Figure 1.3) (Core et al., 2012). Other studies have shown 
Pol II at the 5’ end of genes but have not determined its phosphorylation status or 
whether it is actively engaged in transcribing; I refer to this as poised Pol II 
(Adelman and Lis, 2012). In Drosophila early embryos, many developmental 
regulators,  such as Hox  genes, contain  poised  Pol  II  prior  to  gene  activation 
 














Establishment and release of promoter proximal paused Pol II. (a) Promoter 
opening is often associated with binding of sequence-specific transcription 
factors (shown as TF1) and recruiting chromatin remodelers (blue oval) to create 
an accessible chromatin environment for the assembly of transcriptional 
machinery. (b) The preinitiation complex (PIC) containing general transcription 
factors and RNA polymerase II is recruited to a promoter region. Sequence-
specific transcription factors also involve in regulating the recruitment of PIC. (c) 
Pol II pausing after transcriptional initiation involves the association of 5,6-
dichloro-1-b-D-ribofuranoxyl-benzimidazole sensivitiy-inducing factor (DSIF) and 
negative elongation factor (NELF). The paused Pol II is phophorylated on Ser5 of 
its CTD. (d) Pause release is regulated by the recruitment of p-TEFb directly or 
indirectly through sequence-specific transcription factors (shown as TF2). p-
TEFb phosphorylates DSIF, NELF, and the Pol II CTD to release paused Pol II. 
(e) After paused Pol II is released to productive elongation, another Pol II 
complex might form at promoter region for efficient RNA expression (Adopted 
from Adelman and Lis, 2012). 
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(Zeitlinger et al., 2007). These data suggest that Pol II poising is an important 
regulatory step in transcriptional regulation.         
 
1.3.2 Mechanism of promoter proximal Pol II pausing 
Several DNA sequence motifs and sequence-specific binding factors are 
involved in setting up Pol II pausing. Sequence analysis of paused genes in 
Drosophila embryos indicated that paused promoters tend to be more GC-rich in 
sequence  (Hendrix et al., 2008).  Several sequence motifs are overrepresented 
in paused promoters, such as the downstream promoter element (DPE; 
RGWYV(T)), the initiator motif (Inr motif; YYANWYY), the pausing button (PB; 
KCGRWCG), and the GAGA motif (Hendrix et al., 2008; Lee et al., 2008). Among 
these motifs, the GAGA motif is bound by GAGA factor (GAF), which encodes a 
Trithorax-like protein and alters the chromatin environment via disrupting 
nucleosome assembly at the core promoters in favor of Pol II occupancy 
(Gilchrist et al., 2010). The nucleosome-free chromatin of the paused promoters 
results in long Pol II dwelling and allows DSIF and NELF to bind to the nascent 
transcripts and form a stable paused Pol II complex at promoter proximal regions 
(Missra and Gilmour, 2010). However, GAF-associated Pol II pausing only 
accounts for 20% of paused genes in Drosophila. This result suggests that other 
factors are involved in regulating Pol II pausing.  
A recent study found that a previously identified core promoter element, 
Motif 1 (Ohler et al., 2002), was enriched in the paused genes lacking the GAGA 
motif (Li and Gilmour, 2013). Using affinity chromatography, Li further identified a 
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novel, ubiquitously expressed zinc finger protein specifically bound to Motif 1 in 
Drosophila embryos, named Motif 1 binding protein (M1BP). Different from GAF-
mediated strong Pol II pausing, M1BP-bound genes showed a lower level of Pol 
II pausing (Li and Gilmour, 2013). Gene ontology analysis indicated that M1BP 
bound genes are enriched for basic cellular processes and exhibited more 
uniform expression during development. In contrast, GAGA factor is associated 
with Pol II pausing at developmentally regulated genes (Li and Gilmour, 2013). 
The difference in gene function and expression patterns as well as the level of 
paused Pol II suggests that the mechanism of M1BP-mediated Pol II pausing is 
distinct from that of GAF. In Drosophila, these two factors are responsible for 
~50% of paused genes, which implies that other factors might be involved in 
setting up pausing at genes in different regulatory programs.  
 
1.3.3 Regulation of gene expression through Pol II pausing 
The accumulation of Pol II at promoter proximal regions suggests that the 
expression of these genes is regulated by releasing paused Pol II to promote 
productive transcriptional elongation, which is associated with phosphorylation of 
Serine 2 (Ser2) within the C terminal domain (CTD) of Pol II (Hirose and 
Ohkuma, 2007; Ni et al., 2004). The release of paused Pol II relies on the activity 
of P-TEFb (positive transcription elongation factor b) to phosphorylate its 
substrates including Pol II, DSIF, and NELF (Wada et al., 1998; Yamaguchi et 
al., 2013; Yamaguchi et al., 1999). This observation indicates that regulation of 
P-TEFb is a central node to control expression of poised genes. Several 
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sequence-specific transcription factors, for example c-Myc, NF-κB, MyoD, and 
estrogen receptor, have been shown to recruit P-TEFb to activate its targets 
through direct interaction with P-TEFb (Barboric et al., 2001; Rahl et al., 2010; 
Simone et al., 2002; Welboren et al., 2009). P-TEFb is also a component of 
complexes including the super elongation complex (SEC) (Luo et al., 2012). SEC 
is a massive complex containing a large number of proteins called Mediators, 
which provide a scaffold to bridge protein-protein interactions in regulating 
transcription (Luo et al., 2012; Takahashi et al., 2011). Therefore, sequence-
specific transcription factors could directly or indirectly regulate transcription 
elongation through interacting with SEC. 
 
1.3.4 Function of Pol II pausing in development 
Pol II pausing has been implicated as an important checkpoint in 
regulating gene expression during development. In Drosophila embryos, Pol II is 
poised at a subset of genes that are inactive in certain cell types and tissues, 
such as brinker (brk), which is expressed in neurectoderm but inactive and 
poised in mesodermal cells (Zeitlinger et al., 2007). In contrast, Pol II is also 
poised at another set of developmentally regulated genes that are actively 
expressed at later developmental time points. These observations suggest two 
developmental functions for Pol II poising. Poised Pol II could be an indication of 
transcriptional repression and also reflect a memory of prior transcriptional 
activity. On the other hand, poised Pol II could act as a preparation of gene 
activation at later developmental stages. 
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The poising of Pol II at developmental regulator genes expressed at later 
stages suggests a preparation for rapid gene activation to execute 
developmental decisions. The fast induction of poised genes has been reported 
from studies of Drosophila hsp70 (Wilkins and Lis, 1997). In addition, poised 
genes tend to activate in a synchronous manner compared to nonpoised genes, 
which are more variable and stochastic, as determined by in situ hybridization in 
Drosophila embryos (Boettiger and Levine, 2009). Switching poised genes to 
nonpoised or weakly poised promoters resulted in disrupting the synchronous 
patterns of gene expression and caused morphogenetic defects (Lagha et al., 
2013). This study suggests that the rapid and synchronous activation of poised 
genes is crucial to coordinate temporal gene expression required for specific 
developmental processes. 
On the other hand, Pol Il poising can function to maintain an open 
chromatin configuration. The long dwelling time of poised Pol II at promoter 
proximal regions inhibits nucleosome assembly at the core promoters; therefore 
maintaining these promoters in an open conformation. This idea is supported by 
several studies. The loss of paused Pol II by reducing NELF leads to increased 
nucleosome occupancy and silencing of gene expression at several highly 
poised genes (Gilchrist et al., 2008). Comparing the nucleosome profiles 
between poised and nonpoised promoters showed a significant correlation of Pol 
II poising and nucleosome deprivation around the transcription start site (TSS) 
(Gilchrist et al., 2010). Keeping promoters in an open chromatin configuration 
may facilitate rapid or synchronous induction of gene activation and the recycling 
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of Pol II complex to re-enter the promoters for the next round of transcription, for 
example in response to cell signaling. Overall, Pol II poising provides a layer of 
control in the regulation of gene expression required for robustness of 
development.   
 
1.3.5 Pol II poising in C. elegans 
To date, the most pronounced Pol II poising in C. elegans has been 
identified in young larvae (L1) arrested in development by lack of food (Baugh et 
al., 2009). In starved L1 larvae, Pol II poised specifically at growth and 
developmental genes, whose expression was repressed in response to 
starvation but later resumed expression when food became available (Baugh et 
al., 2009). This study indicates that Pol II poising reflects the memory of 
expression, but perhaps also the priming for future transcription in response to 
feeding. 
A recent study might explain how Pol II pausing is regulated during L1 
starvation. During starvation or under environmental stress, an unknown signal 
can induce the recruitment of the nuclear protein ZFP-1 and histone 
methyltransferase DOT-1.1 to widely-expressed essential genes (Cecere et al., 
2013). These genes included the growth genes previously reported to be paused 
during L1 starvation (Baugh et al., 2009). The recruitment of the ZFP-1/DOT1.1 
complex resulted in the increase of methylation of histone H3 at position 79 
(H3K79), which was associated with slowing Pol II and poising at promoters 
(Cecere et al., 2013). This study revealed a negative feedback mechanism to 
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mediate gene expression through Pol II pausing in response to environmental 
stimuli. This result also highlights the connection of histone modification in 
regulating Pol II dynamics, which might provide a framework to unravel the 
molecular mechanism of Pol II pausing. 
Distinct from Drosophila, Pol II pausing in C. elegans embryos is relatively 
rare (Kruesi et al., 2013; Zhong et al., 2010). Pol II ChIP-Seq performed by 
modENCODE identified ~2% of genes exhibited 5’ stalled Pol II in mixed-stage 
embryos (Zhong et al., 2010). A recent publication from the Meyer and Lis labs 
further indicated that few genes, only 0.38% of genes in embryos, were 
associated with transcriptionally engaged and paused Pol II using Global Run On 
Sequencing (GRO-Seq) (Kruesi et al., 2013). This phenomenon might be 
explained by the lack of several pausing factors from C. elegans, such as GAGA 
factor and NELF. The mechanism of Pol II poising in arrested L1 larvae 
mentioned above might be distinct from the mechanisms to regulate Pol II 
poising in embryos.   
Studies that have combined RNA-Seq and Pol II ChIP-Seq have 
suggested that Pol II occupancy is dynamic. In C. elegans arrested L1 larvae, Pol 
II was poised at growth genes during starvation. Within an hour after feeding, Pol 
II occupancy at promoters decreased as genes responding to food and started to 
express (Baugh et al., 2009). This is similar to studies with Drosophila in which 
Pol II was dynamically regulated during embryogenesis (Gaertner et al., 2012). 
Genes lacked poised Pol II at early stages and gained Pol II prior to transcription. 
Intriguingly, poised Pol II was found in multiple tissues, including those that would 
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never transcribe the particular genes. Thus, in Drosophila embryos, poised Pol II 
reflects temporal but not cell type-specific regulation (Gaertner et al., 2012). 
These data suggest that Pol II poising is dynamically regulated and stage-
specific. Therefore, careful examination of Pol II poising in C. elegans embryos 
requires using synchronized populations.  
 
1.4 Pharynx development provides a model to study 
temporal gene expression 
Pharynx development in C. elegans is driven by temporal activation of 
subsets of pharyngeal genes at each developmental stage. This process is tightly 
regulated by PHA-4 activity. Therefore, pharynx development is a good model to 
explore different mechanisms in controlling temporal gene expression during 
development, including Pol II poising. In fact, the feature of PHA-4 function as a 
pioneer factor makes it appealing to test whether PHA-4 modulates temporal 
pharyngeal activation through Pol II poising. The PHA-4 activity to induce 
chromatin decompaction might facilitate the recruitment of Pol II or reflect the 
exchange of a nucleosome for Pol II. These ideas have not been tested nor have 
pioneer factors been reported to be involved in Pol II poising.  
The motivation of this study is to better understand how selector genes 
contribute to temporal gene expression in controlling complex developmental 
processes, such as organ formation. In this thesis, I focused on studying events 
that occur upstream of temporal gene expression by examining PHA-4 binding to 
various pharyngeal promoters and their transcriptional outcomes (Chapter 2). 
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Next, I examined patterns of genome-wide Pol II occupancy at pharyngeal genes 
(Chapter 3). Results from my studies indicated that DNA binding site affinity 
affects the level of PHA-4 occupancy at target promoters to modulate the onset 
of pharyngeal gene expression. PHA-4-controlled temporal pharyngeal gene 
expression is partly through regulating RNA Pol II occupancy at pharyngeal 
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2.1 Abstract 
 The formation of organs is often controlled by selector genes, which 
encode a special class of transcription factors. In C. elegans, the forkhead 
transcription factor PHA-4/FoxA plays an integral role in all aspects of 
foregut/pharynx development by directly activating both early and later expressed 
pharyngeal genes during embryogenesis. The temporal control of pharyngeal 
expression is fine-tuned by PHA-4 binding site affinity within the target 
promoters. Mutation of a high affinity PHA-4 binding site to a lower affinity site 
delays the onset of target gene expression; conversely, increasing binding site 
affinity advances gene activation. To address the molecular mechanism of PHA-
4 controlled temporal gene expression through binding site affinity, we probed 
the PHA-4 binding to different targets by the Nuclear Spot Assay and Chromatin 
Immunoprecipitation. PHA-4 was found to bind to its targets before active 
transcription, and the level of PHA-4 occupancy was affected by the affinity of 
binding sites within the target promoters. Changing PHA-4 levels by 
overexpression or reducing PHA-4 expression during development to affect PHA-
4 occupancy at its targets resulted in advanced or delayed pharyngeal gene 
expression. Our results demonstrate that binding site affinity regulates the level 
of PHA-4 occupancy at target promoters to modulate temporal gene expression. 
This study provides insights into understanding how a single selector gene 
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2.2 Introduction 
 Organ formation is a complex developmental process involving early cell 
fate specification followed by cell differentiation and functional morphogenesis. 
Organogenesis is driven by successive differential gene expression that is often 
controlled by organ selector genes, which encode a special class of transcription 
factors. Organ selector genes are defined based on the absolute requirement of 
their activity on organ formation; organogenesis is blocked at the earliest 
specification stage in the absence of selector genes (Mann and Carroll, 2002). 
Organ selector genes function as transcription factors that establish downstream 
gene expression profiles needed to generate an organ primordium. Ectopic 
expression of an organ selector gene induces ectopic expression of organ 
specific genes and can lead to transformation of cell identify (Fukushige and 
Krause, 2005; Kiefer et al., 2007; Zhu et al., 1998).  
 pha-4 in C. elegans is a well-characterized organ selector gene, which 
encodes a forkhead transcription factor orthologous to mammalian FoxA and 
Drosophila forkhead transcription factors (Horner et al., 1998; Kalb et al., 1998). 
PHA-4/FoxA is required for specification of the foregut in mammals (Kaestner, 
2010) and pharynx development in C. elegans (Mango et al., 1994). The C. 
elegans pharynx is a pumping and feeding organ composed of multiple cell 
types, including epithelial, neural, gland, valve, muscle, and structural cells. 
Embryos lacking pha-4 fail to form the pharynx and die of starvation soon after 
hatching (Horner et al., 1998; Kalb et al., 1998; Mango et al., 1994). As might be 
predicted for a selector gene, PHA-4 is the earliest pharyngeal marker and is 
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expressed throughout the pharynx during development regardless of cell lineage 
or the adopted fates of subpharyngeal cell types. Previous microarray analyses 
identified pharyngeal genes expressed at different stages. The promoters of 
these genes contain at least one consensus PHA-4 binding site “TRTTKRY” (R = 
A/G, K = T/G, Y = T/C), and their pharyngeal expression is dependent on PHA-4 
binding sites (Gaudet and Mango, 2002; Zhong et al., 2010). This result indicates 
that PHA-4 is a master regulator of pharyngeal transcription.  
 How PHA-4 controls pharyngeal gene expression patterns during pharynx 
development is a central question in understanding the mechanism of temporal 
gene activation. Previous studies from the Mango lab have shown that PHA-4 
binds to different TRTTKRY consensus sequences found at endogenous targets 
with differential affinity and regulates temporal pharyngeal gene expression partly 
through its binding affinity to target promoters. Mutation of a high affinity PHA-4 
binding site to a lower affinity site within the context of a pharyngeal promoter 
construct delays the onset of promoter-fused reporter gene expression. 
Conversely, increasing the binding site affinity advances pharyngeal activation of 
the reporters (Gaudet and Mango, 2002). These data suggest that binding site 
affinity influences the timing of pharyngeal onset, within the context of natural 
promoters.  
 Binding affinity between transcription factors and their recognition 
consensus sequences is used in many regulatory contexts. For example, the 
morphogen Dl (Dorsal) forms a concentration gradient along the dorsoventral 
axis of the Drosophila embryo and activates spatial gene expression. Targets 
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with high affinity Dl sites are expressed at lateral regions with lower Dl levels, 
whereas targets containing low affinity Dl sites only express at the ventral 
mesoderm in response to high Dl levels (Stathopoulos and Levine, 2004). 
Moreover, binding site affinity also contributes to control the level of gene 
expression. Studies of the transcription factor Pho4 and phosphate homeostasis 
in yeast revealed that Pho4 induces low levels of PHO5 by binding to a low 
affinity site, whereas high levels of PHO84 are induced due to its high affinity site 
bound by Pho4 in intermediate phosphate conditions (Lam et al., 2008; Springer 
et al., 2003). PHO5 is not highly expressed until phosphate starvation induces 
substantial Pho4 accumulation in the nucleus, which may saturate available 
binding sites.  
These cases all suggest that binding site affinity is sensitive to the 
concentration of transcription factors. Similar to the proposed PHA-4 affinity 
model, we hypothesize that high affinity PHA-4 sites, but not low affinity sites, are 
bound by PHA-4 at early embryonic stages when PHA-4 levels are low. Low 
affinity PHA-4 targets are bound and activated until later stages when PHA-4 
levels are increased. The promoter occupancy of a given transcription factor is 
predicted to be different among different affinity sites since the transcriptional 
outcome has proven to be affected. However, the effect of binding site affinity on 
the level of transcription factor occupancy has not been carefully examined in 
vivo due to the lack of a well-controlled system. In this study, I examined 
pharyngeal expression in response to changes in PHA-4 levels and probed PHA-
4 binding to different affinity sites in living embryos. The results indicated that 
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DNA binding site affinity affects the level of PHA-4 occupancy on target 
promoters. Understanding the basic biophysical dynamics of transcription factor 
binding strength to different DNA targets is important to help unravel the 
molecular mechanisms of transcriptional control, such as the downstream 
recruitment of macromolecular complexes including RNA Polymerase II and 
general transcription factors.   
 
2.3 Materials and methods 
 
2.3.1 Strains and growth conditions 
Strains were provided by the Caenorhabditis Genetics Center and 
maintained at 20°C, except for the stated strains. Bristol N2 was used as the wild 
type strain. KK822 par-1(zu310ts)V  was maintained at 24°C and shifted to 15°C 
at the L4 stage overnight to collect embryos. For the Nuclear Spot Assay (NSA), 
the following strains were used: SM1630 cha-1 (p1182); pxEx274 (cha1 + 
H2AZpro::lacI::cfp + PHA-4::YFP+M05B5.2-Down + lacO + Sperm DNA), 
SM1636 cha-1(p1182); pxEx275(cha-1 + H2AZpro::lacI::cfp +PHA-4::YFP + 
M05B5.2-WT  + lacO + Sperm DNA), SM1703 cha-1(p1182); pxEx333(cha-1 + 
H2AZpro::lacI::cfp + PHA-4::YFP + Ceh-22 WT + lacO + Sperm DNA), SM1704 
cha-1(p1182); pxEx334(cha-1 + H2AZpro::lacI::cfp+PHA-4::YFP + Ceh-22 Up + 
lacO + Sperm DNA). Transgenic worms generated for the NSA were grown at 
24°C. For the pha-4 heat shock experiment, SM295 pxEx(HS::PHA-4 + pax-
1::GFP + UL8::lacZ + pRF4 + 1 KB ladder + Herring Sperm DNA) was used and 
maintained at 15°C. For the pha-4 RNAi experiment, OK29 culs1[ceh-22::GFP + 
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pRF4(rol-6(su1006))] was used. For Chromatin Immunoprecipitation (ChIP), 
SM1754 stIs10389 (pha-4::gfp::3xFLAG), SM2078 stls10389 (PHA-
4::GFP::3XFLAG), and pha-4 (q500) rol-9(sc148) were used.  
 
2.3.2 Antibody stains 
For quantification of PHA-4 levels during embryogenesis, wild type embryos were 
isolated and fixed for staining as described previously (Kiefer et al. 2007). The 
primary antibodies used were MAB052 (anti-pan histone) at 1:1000 dilution 
(Millipore Cat # NG1752060) and anti-PHA-4 Ab at 1:2000 dilution (Kaltenbach et 
al., 2005). The secondary antibodies were Alexafluor 488 goat anti-rabbit 
(Alexafluor Cat # a11008) and Alexa Fluor 647 goat anti-mouse at 1:200 dilution. 
Slow Fade with 4',6-diamidino-2-phenylindole (DAPI) (Molecular Probes) was 
used as a mounting medium. 
 
2.3.3 Image analysis 
For quantification of relative PHA-4 protein levels during embryogenesis, 
in situ PHA-4 staining of different staged embryos was imaged. Z-stack images 
covering the whole pharynx were taken at 0.5 um increments. The 3D images of 
multiple embryos at each embryonic stage were reconstructed and analyzed by 
Volocity imaging analysis software (PerkinElmer). The measurement protocol 
was created to first select nuclei (objects) in the embryos based on both DAPI 
and histone staining. The intensity of PHA-4 staining within pharyngeal nuclei 
was then measured and the staining signal in nonpharyngeal nuclei was 
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subtracted as background. The PHA-4 level at each embryonic stage was 
calculated as follows: (PHA-4 intensity in pharyngeal nuclei / the volume of total 
measured pharyngeal nuclei) – (background signal in nonpharyngeal nuclei/ the 
volume of nonpharyngeal nuclei). The PHA-4 staining in terminal-staged par-1 
embryos on each slide was analyzed by the same measurement and used to 
normalize the staining variation from slide to slide. The ratio of PHA-4 intensity 
during each stage in wild type embryos to the PHA-4 intensity of par-1 embryos 
on the same slides was used to compare the relative PHA-4 levels during 
embryogenesis. The numbers of endodermal cells (for early embryos) and 
embryonic morphology (for mid- to late embryos) determined the stages of 
embryos. 
 
2.3.4 pha-4 heat shock assay 
Two-cell embryos were collected from SM259 worms containing pha-4 
heat shock expression constructs. Two-cell embryos were incubated in the 0.2 
mL polymerase chain reaction (PCR) tubes at 20°C using a thermalcycler for 75 
minutes (2E), 120 minutes (4E), 3 hours (8E), and 5 hours (16E) prior to heat 
shock at 33°C for 30 minutes as previously described (Kiefer et al., 2007). After 
heat shock, embryos were recovered at 20°C to reach the desired stages (8E, 
16E, and bean) for analysis. Images were acquired from embryos using a Zeiss 
confocal microscope (LSM 710).  
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2.3.5 pha-4 RNAi assay 
 RNAi induced by bacterial feeding was performed as previously described 
(Updike and Mango, 2007). HT115 bacteria expressing dsRNA of mCherry and 
pha-4 was grown at 37°C overnight. 10 uL overnight culture was used to 
inoculate 5 mL lysogeny broth (LB) medium and continued to incubate at 37°C. 
After 6–8 hours, bacterial growth was measured by absorbance at 600 nm. Both 
mCherry and pha-4 bacteria cultures were diluted to the same optical density 
(OD) pha-4 RNAi was then diluted to 1/2, 1/4, and 1/8 strength with mCherry 
RNAi culture. Bacteria were spun down at 2400 rpm for 20 minutes and 
resuspended in LB medium. Standard nematode growth media (NGM) plates 
were seeded with 50 uL of bacteria on each plate and allowed to dry overnight. 
20–25 L4 OK29 worms were plated on RNAi plates and incubated at 25°C 
overnight. Embryos on the RNAi plates were collected, fixed and stained with 
anti-GFP (to recognize ceh-22::GFP) and anti-PHA-4 antibodies. Expression was 
analyzed as described above.     
 
2.3.6 DNA constructs 
 For the Nuclear Spot Assay, the following constructs were used to 
generate the extrachromosomal arrays: SEM544 (M05B5.2 wild type promoter), 
SEM462 (M05B5.2 down mutation), SEM542 (ceh-22 wild type promoter), 
SEM561 (ceh-22 up mutation), SEM545 (ceh-22 promoter with a disrupted PHA-
4 binding site), and SEM692 (Ppha-4::PHA-4::YFP). Primers C2-67-F and C2-67-
B were used to amplify the M05B5.2 wild type promoter from SEM544. Primers 
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C2-67-B and C2-67-del-3 were used to amplify the M05B5.2 down mutation 
promoter from SEM462. Primers C22-non-F2 and CEH22-B were used to amplify 
the ceh-22 wild type promoter from SEM542. Primers ceh-22-per-F and CEH22-
B were used to amplify the ceh-22 up mutation promoter from SEM561. Primers 
C22-non-F3 and CEH22-B were used to amplify the ceh-22 promoter with a 
disrupted PHA-4 site from SEM545. Primer sequences are listed below: C2-67-F 
(TTGGTCTAGATTGGCAAACAATCTGAAAGCT), C2-67-B (GGTCGGTACCT 
AGACTATCTGAATAATTGATAATTG), C2-67-del-3 (CATGTCTCGGAGAGAGG 
AAGG), C22-non-F2 (CATAATCTATATATTTGTCTTGATGGAAATATTTAAGTA 
TCCG), CEH22-B (TCCAGGATCCACACGTTGAACATCGGCT), ceh-22-per-F 
(CATAATCTATATGTTTGCCTTGATGGAAATATTTAAG), and C22-non-F3 (CA 
TAATCTATATACCGGTCTTGATGGAAATATTTAAGTATCCG) 
 
2.3.7 Nuclear spot assay (NSA) 
Transgenic lines for the Nuclear Spot Assay were as follows: M05B5.2 
wild type promoter (SM1702), M05B5.2 promoter with a mutagenized low affinity 
PHA-4 binding site (SM1630), ceh-22 wild type promoter (SM1703), and ceh-22 
promoter with a mutagenized high affinity PHA-4 binding site (SM1637 and 
SM1704). Nuclear spot assays were set up and performed as previously 
described (Kiefer et al., 2007; Updike and Mango, 2006), and the live images of 
embryos were acquired using the Olympus FV1000 Confocal Laser Scanning 
Microscope as described previously (Fakhouri et al., 2010). The number of 
endoderm cells and the morphology of embryos were used to determine 
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embryonic stages. Volocity imaging analysis software (PerkinElmer) was used to 
perform spatial measurement of array size and intensity of PHA-4::YFP. The 
measurement protocol was generated to select Lacl::CFP (citrine fluorescence 
protein) (array) areas and PHA-4::YFP (yellow fluorescence protein) positive 
cells using an intensity threshold. After the separation of touching objects, 
removal of noise, and exclusion of objects smaller than 0.2 um2, the intensity of 
PHA-4::YFP in each pharyngeal cell of different-staged embryos was measured. 
PHA-4::YFP signal that overlapped with LacI::CFP was measured separately and 
viewed as “PHA-4::YFP binding to the array.” The levels of PHA-4 binding to 
arrays carrying different affinity sites were calculated based on the ratio of PHA-
4::YFP intensity on the array to total PHA-4::YFP intensity in the same nucleus. 
 
2.3.8 Embryo staging and crosslinking for chromatin  
immunoprecipitation 
Starved SM2078 L1 larvae from 4–5 6 cm OP-50 plates were washed and 
grown in 4 large 10 cm HB101 plates until worms were gravid. The worms were 
then bleached to collect embryos. Embryos were transferred to a large plate 
without food to obtain a synchronized L1 larval population. The L1 larvae were 
then transferred and evenly spread to 20–30 large HB101 plates and grown at 
20°C. Worms were harvested and bleached after proximately 56–60 hours 
incubation until young adult worms have only 1–2 fertilized embryos in the 
gonads. After bleaching the worms, most of the embryos harvested were 1–4 cell 
embryos. The embryos were suspended in 1 ml M9 buffer and put on an agar 
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plate without food for aging to desired developmental stages. These early (1–4 
cells) embryos were incubated at 20°C for 3 to 3.5 hours to reach the 8E stage, 
5–6 hours to reach the bean stage and 8–10 hours to reach the 2-fold stage. The 
aged embryos were washed and spun down for harvest. The embryo pellets 
were flash frozen in liquid nitrogen, followed by thawing on ice for one cycle to 
crack the eggshell. The embryos were cross-linked by 900 uL 1.5% 
formaldehyde in M9 for 30 minutes with rotation. 100 uL of 1.25M glycine was 
added and the pellet incubated for 5 minutes to quench the excess 
formaldehyde. The embryo pellets were then washed 3 times with cold M9 with 
protease inhibitors (CalBiochem Protease Inhibitor Cocktail Set 1). Washed 
pellets were then used immediately for ChIP or stored at -80oC. 
 
2.3.9 Chromatin immunoprecipitation (ChIP) 
Approximately 300,000 formaldehyde cross-linked embryos were 
suspended in 300 uL of lysis buffer (50mM Tris pH 8.0, 10mM EDTA pH 8.0, 
0.2% SDS, 1x complete ethylenediaminetetraacetic acid (EDTA) protease 
inhibitor, 1x PhosStop) and incubated on ice for 30 minutes. Using a QSonica 
Q700 Sonicator, the samples were sonicated at the following settings: 80% 
amplitude, 30 seconds on, 30 seconds off and 40 cycles. After sonication, the 
extracts were spun for 15 minutes at 14,000 RPM at 4°C to remove the debris. 
The supernatant was transferred to new tubes. Chromatin concentration was 
measured using a Nanodrop and 15 ug of chromatin was used per ChIP reaction. 
15 ug of chromatin was diluted in ChIP dilution buffer (0.01% SDS, to 1.1% Triton 
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X-100, 1.2mM EDTA, 16.7mM Tris-HCl pH 8.1, 167mM NaCl) to 1 mL and 
precleared for 1 hour at 4°C with protein A agarose beads. 10% of ChIP material 
was saved as input. For each ChIP, 5 uL of GFP trap-M antibody (Chromoteck) 
was used to pull down PHA-4::GFP. The immunocomplexes were then incubated 
at 4°C on a rotator for 15–17 hours. After incubation, the beads were washed 
twice by ChIP dilution buffer, twice by low salt buffer (0.1% SDS, 1% Triton X-
100, 2mM EDTA, 20mM Tris-HCl pH 8.1, 150mM NaCl), twice by high salt buffer 
(0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl pH 8.1, 500mM NaCl), 
once by LiCl buffer (100mM Tris pH 8.0, 500mM LiCl, 1% deoxycholic acid, 1% 
NP-40) and three times by TE buffer (10mM Tris pH 8.0, 1mM EDTA pH 8.0) for 
5 minutes on the rotator. To elute the bound immunocomplexes, 150 uL of 
elution buffer (50mM NaHCO3, 140mM NaCl, 1% SDS) were added to each tube 
and heated at 55°C for an hour with vortexing every 5 to 10 minutes. From this 
point, the ChIP and input samples were then treated the same way to release the 
DNA. 1 uL of RNaseA (200 mg/mL) was added, followed by incubation at 37°C 
for 30 minutes. To reverse the cross-links, 2 uL of proteinase K (10 mg/mL) were 
added and incubated at 65°C overnight. The released DNA was purified using a 
Qiaquick PCR purification kit (Qiagen) and eluted twice with 50 uL of elution 
buffer. For construction of the sequencing library, the DNA was purified and 
concentrated by using MinElute Reaction Cleanup Kit (Qiagen) and eluted twice 
with 10 uL of elution buffer. 
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2.3.10 Quantitative PCR 
For measuring the promoter copy numbers of different NSA strains, 
genomic DNA was isolated from individual strains (Fakhouri et al., 2010). 
Specific primers targeting M05B5.2 and ceh-22 promoters as well as pha-4::yfp 
were used and normalized to an internal control  (actin, act-1). The relative copy 
numbers of promoters and exogenous pha-4::yfp were determined using 2-ΔΔCt 
method.  
For quantification of ChIP signals, specific primers (see Table A.1 in the 
Appendix for primer sequences) against PHA-4 targets and genomic regions 
were used to detect PHA-4 binding. Each primer set used was calibrated by a 
standard curve using multiple dilutions of template DNA isolated from cross-
linked and sonicated chromatin to quantify the enrichment of binding relative to 




2.4.1 PHA-4 expression changes dynamically during  
embryogenesis 
The model of affinity suggests that the amount of PHA-4 in the pharyngeal 
nuclei would impact the pharyngeal gene expression. PHA-4/FoxA is activated at 
early embryonic stages and maintained throughout the whole lifespan, as 
determined by GFP-based transcriptional and translational reporters (Azzaria et 
al., 1996; Horner et al., 1998). However, the dynamic change in PHA-4 
expression level during embryogenesis was not well studied until a recent pha-4 
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mRNA expression profile was reported (Levin et al., 2012). The pha-4 mRNA 
expression was measured in whole embryos in which pha-4 expresses in the 
pharynx, intestine, and rectum. To determine the changes of PHA-4 protein 
levels specifically in the pharynx during embryogenesis, we employed a sensitive 
approach to quantify endogenous PHA-4 protein by PHA-4 antibody staining in 
embryos. The PHA-4 protein level was measured by counting pixels in a region 
of interest for the pharynx. The protein concentration of PHA-4 at each 
embryonic stage was calculated based on the total pixels in a measured area 
divided by the volume of the area. The average protein concentration of PHA-4 
was then subtracted by the background staining signal in nonpharyngeal nuclei 
measured and calculated using the same formula mentioned above. The par-1 
mutant embryos that contain excess pharyngeal cells were mixed with wild type 
embryos as an on-slide control for antibody staining. The relative PHA-4 protein 
concentration at each embryonic stage was determined by normalization to PHA-
4 levels in par-1 (Figure 2.1A) (Kaltenbach et al., 2005; Updike and Mango, 
2007). PHA-4 protein was first detectable at the 2-endodermal cell (2E) stage, 
around 60–100 minutes after the first cleavage when embryos contain total ~28 
cells). Quantified by protein concentration, PHA-4 expression increased 10-fold 
during the first half of embryogenesis. PHA-4 expression reached a plateau at 
the bean stage at which the pharyngeal primordium is formed. PHA-4 expression 
was maintained during mid-embryogenesis and decreased slightly at later 
embryonic stages (Figure 2.1B). This trend of dynamic PHA-4 expression during 
embryogenesis  is  similar  to  pha-4  mRNA   profiles   (Levin  et  al.,  2012)   but 
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Figure 2.1  
PHA-4 expression changes dynamically during embryogenesis. (A) PHA-4 
staining patterns in wild type and par-1 mutant embryos. PHA-4 expression level 
at each embryonic stage was quantified by measuring the signal intensity of 
PHA-4 within the pharyngeal cells and subtracting the background staining in 
nonpharyngeal cells. The ratio of PHA-4 level at each individual stage to PHA-4 
intensity in par-1 mutant embryos on the same slide was used as an internal 
control to compare staining. (B) The changing of relative PHA-4 level during 
embryogenesis in wild type and PHA-4::GFP strain. PHA-4 level in the 
pharyngeal cells increases during the first half of embryogenesis and decreases 
slightly during the later embryonic stages. PHA-4::GFP strain was  the same 
strain used in modENCODE studies (Zhong et al. 2010) (SM1754; see materials 
and methods) Timing (minutes after first cleavage) and corresponding embryonic 
stages at 20°C: 2E (~60-100 min), 4E (~after 100 min), 8E (~180 min), pre-bean 
(16E) (~280 min), bean (~300-360min), comma (~400 min), 1.5 fold (~440 min), 
2 fold (~480 min), and 3 fold (~540 min). 
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consistently delayed. The delay of timing may reflect the time required for protein 
synthesis.  
Using the same strategy of PHA-4 staining to quantify total PHA-4 levels 
of the integrated PHA-4::GFP strain (SM1754) utilized for the modENCODE 
project (Zhong et al., 2010), we determined that the PHA-4 level of PHA-4::GFP 
strain is 2–3-fold higher than wild type (Figure 2.1B, data shown in green line). 
This PHA-4::GFP strain (SM1754) is in a wild type genetic background which 
also expresses endogenous PHA-4. This result suggests that a 1–2-fold increase 
of PHA-4 protein level is expressed by extra copies of integrated pha-4::gfp. In 
later studies, we generated a pha-4 rescued strain (SM2078; see materials and 
methods) by crossing the PHA-4::GFP strain to a pha-4 mutant  (pha-4(q500); 
(Mango et al., 1994) in which PHA-4::GFP is the only source of functional PHA-4 
and the total PHA-4 level is similar to wild type.    
 
2.4.2 Adequate PHA-4 is crucial to maintaining precise  
temporal pharyngeal expression  
PHA-4 activity is essential for developmental viability, as evidenced by 
shifting the pha-4 temperature-sensitive strain to the restrictive temperature at 
different stages during development. Eliminating PHA-4 activity at early 
embryonic stages (after the formation of pharyngeal precursors) caused 100% 
lethality and a complete absence of the pharynx. In addition, abrogating PHA-4 at 
later stages (before the pharynx fully developed) resulted in a range of 
pharyngeal defects, such as Pun or a stuffed pharynx (defects in pharyngeal 
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pumping) (Gaudet and Mango, 2002; Kiefer et al., 2007). These results indicate 
that maintaining PHA-4 levels is required for pharyngeal gene expression at both 
early and late embryonic stages. We first asked if endogenous pharyngeal gene 
expression is affected in the PHA-4::GFP strain (SM1754), which contains 2–3- 
fold more PHA-4 protein compared to wild type. Two endogenous pharyngeal 
muscle targets, a pharyngeal muscle epitope 3NB12 (Priess and Thomson, 
1987) and pharyngeal muscle myosin, were examined by antibody staining in 
SM1754 and wild type embryos. The antibody staining showed that the onset of 
two pharyngeal muscle targets is normally regulated as in wild type (data not 
shown). This result implies that temporal pharyngeal expression was maintained 
properly within a 2–3-fold increase in PHA-4 levels. To understand the 
pharyngeal defects caused by abnormality of PHA-4 activity, we examined the 
patterns of pharyngeal gene expression by changing PHA-4 levels in a wider 
range than 2–3-fold during development. Ectopic PHA-4 expression was placed 
under control of the heat shock promoter to induce PHA-4 overexpression at 
early embryonic stages, specifically at 2E, 4E, 8E, and 16E. PHA-4 expression 
driven by a heat shock promoter was activated ubiquitously in both pharyngeal 
and nonpharyngeal cells. The outcome of pharyngeal expression was detected 
by a Ppax-1::GFP reporter (a direct PHA-4 target) (Figure 2.2A). In wild type and 
no heat shock control embryos, Ppax-1::GFP was activated from the bean stage 
(Figure 2.2B). Heatshock pha-4 at 2E, 4E, and 8E, but not 16E induced 
advanced Ppax-1::GFP expression at 16E.  In addition, Ppax-1::GFP was 
ectopically expressed in nonpharyngeal cells whereas in control embryos without  
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Figure 2.2  
Overexpression of PHA-4 induces advanced pharyngeal expression of pax-
1::GFP. (A) Experimental design: heatshocked pha-4 at 2E, 8E, and 16E for 30 
min and recovered to desired stages. GFP expression was detected at 16E or 
bean stages. Ppax-1::GFP normally turns on at bean stage. (B) The patterns of 
wild type Ppax-1::GFP expression at 16E, bean, and comma stages. Ppax-
1::GFP was first detectable at bean stage in pharyngeal marginal cells. (C) The 
patterns of Ppax-1::GFP expression at 16E under different conditions. No Ppax-
1::GFP expression was detected in control embryos without heat shock at 16E. 
Overexpression of pha-4 by heat shock at 2E and 8E induced advanced and 
ectopic Ppax-1::GFP expression at 16E. Arrows and circled dash line indicate 
pharyngeal cells.	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heat-shock, Ppax-1::GFP was expressed specifically in pharyngeal marginal cells 
(Figure 2.2B and Figure 2.2C). When embryos were heatshocked at the 2E stage 
(n = 19), a larger portion of nonpharyngeal cells responded to PHA-4 activity and 
ectopically expressed Ppax-1::GFP. In comparison, heat-shock at 8E (n = 22) 
induced early onset of pax-1::GFP expression at 16E but resulted in fewer 
nonpharyngeal cells exhibiting ectopic expression. Our data showed that 
increasing PHA-4 levels during early embryogenesis led to advanced activation 
of PHA-4 targets.  
To test the converse, expression of the pharyngeal muscle target, Pceh-
22::GFP, was examined under reduced levels of pha-4 by RNAi. pha-4 RNAi was 
diluted to 1/4 and 1/8 strength in order to score enough number of F1 embryos, 
and Pceh-22::GFP was scored using live imaging. The mCherry RNAi was used 
as a control that did not affect GFP expression. In the mCherry RNAi control 
embryos, Pceh-22::GFP was activated in a subset of pharyngeal muscle cells 
from the bean stage, similarly to its activation in wild type embryos. In embryos 
with pha-4 RNAi, a proportion of bean embryos not expressing ceh-22::GFP 
were observed, while all later embryos (later than comma stage) expressed 
Pceh-22::GFP. The proportion of bean embryos that did not express Pceh-
22::GFP was variable and likely due to the strength of pha-4 RNAi. This result 
from live imaging suggests a delay in Pceh-22::GFP expression when PHA-4 
levels were reduced by RNAi. To verify that the delayed Pceh-22::GFP was due 
to decreased pha-4 activity, PHA-4 levels were quantified in bean stage pha-4 
RNAi-treated  embryos  with or without  detectable  Pceh-22::GFP  expression by 
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antibody  staining of  PHA-4 and  GFP  (Figure 2.3). Surprisingly, we found a 10-
fold decrease in PHA-4 for delayed Pceh-22::GFP bean embryos in comparison 
to bean embryos that were normally activated (Figure 2.3B). This result suggests 
that a low amount of PHA-4 (above approximately 10% of wild type PHA-4) is 
sufficient to maintain the temporal expression of Pceh-22::GFP.  
 
2.4.3 PHA-4 binds to its targets long before activation of  
transcription 
Pharyngeal gene expression depends on PHA-4 activity and the PHA-4 
binding sequences found in target promoters. PHA-4 can activate pharyngeal 
gene expression at different developmental stages (Gaudet and Mango, 2002). 
We speculated that PHA-4 might bind to different targets at different times. For 
example, early expressed pharyngeal genes are bound by PHA-4 earlier than 
pharyngeal genes expressed at later embryonic stages. To understand how 
PHA-4 regulates temporal pharyngeal gene expression through its interaction 
with target DNA, we employed two different methods to study PHA-4 binding to 
pharyngeal promoters. The first approach is through Nuclear Spot Assay (NSA), 
which assays the binding of PHA-4::YFP and LacI::CFP to extrachromosomal 
arrays carrying multiple copies of a pharyngeal promoter of interest and the Lac 
operator (Figure 2.4A) (Kiefer et al., 2007; Fakhouri et al., 2010). The binding of 
LacI::CFP to LacO sequences on the array revealed the location and the size of 
the extrachromosomal array within the nucleus. If YFP and CFP signals 
colocalize,  then   we   can   conclude   that   PHA-4::YFP   associates   with   the  
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Figure 2.3  
Reducing PHA-4 levels results in delayed pharyngeal expression of Pceh-
22::GFP. (A) Representative images of PHA-4 and GFP staining of bean 
embryos that were treated with mCherry or pha-4 RNAi. (B) Quantification of 
relative PHA-4 level in bean embryos treated with RNAi. Bean embryos treated 
with pha-4 RNAi were separated depending on whether or not they had Pceh-
22::GFP expression. A threshold of 10% of PHA-4 level in pha-4 RNAi-treated 
bean embryos distinguished the expression of Pceh-22::GFP expression.  




Nuclear spot assay to visualize PHA-4 binding to its target DNA. (A) 
Experimental design of NSA. LacI::CFP (magenta) bound LacO fragments on 
pseudochromosomes. PHA-4::YFP (green) bound to target promoters on the 
arrays and also within the genome. (Adapted from Fakhouri et al., 2010) (B) 
PHA-4::YFP was enriched on the arrays carrying target promoters with wild type 
PHA-4 binding sites but not on arrays with disrupted sites. Magenta: LacI::CFP; 
green: PHA-4::YFP; white: colocalization of two signals. (C) The amount of PHA-
4 binding to DNA among different affinity sites during development was 
quantified using Volocity. LacI::CFP intensity was measured to track array size, 
which reflected the compactness of the pseudochromosome. 
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pharyngeal promoter on the array. Previous work showed that PHA-4 association 
with an extrachromosomal array containing a pharyngeal promoter is solely 
dependent on the availability of PHA-4 binding sites. PHA-4::YFP was exclusive  
or exhibited a basal intensity with random nuclear distribution at the array 
carrying a promoter with a disrupted PHA-4 binding site (Figure 2.4B) (Fakhouri 
et al., 2010). Through live imaging, NSA offers the advantage to study the 
dynamics of PHA-4 binding to target promoters in the pharyngeal nuclei. 
Therefore, NSA provides temporal and cell-type specific resolution for studying 
the binding of transcription factors to target DNA.  
NSA allows us to study PHA-4 binding to arrays containing PHA-4 targets 
but not endogenous loci. To examine PHA-4 binding to endogenous targets, we 
performed chromatin immunoprecipitation (ChIP), which directly precipitates the 
transcription factor bound-DNA to determine the endogenous targets of studied 
factors. Due to the lack of antibody to precipitate PHA-4 directly, we used an 
alternative approach by generating a transgenic strain which expresses a double-
tagged PHA-4::GFP::3xFLAG construct. This PHA-4::GFP::3xFLAG construct 
rescued the pha-4 mutant phenotype; hence, we used this rescued strain 
(SM2078, see materials and methods) to perform ChIP using antibodies 
recognizing GFP or FLAG. PHA-4::GFP::3xFLAG is the only source of functional 
PHA-4 in the rescued strain and the level of PHA-4::GFP is similar to wild type 
PHA-4 levels. This strategy provided higher sensitivity for investigating the level 
of PHA-4 binding to various targets since there was no competition between 
endogenous PHA-4 and exogenous PHA-4::GFP::3xFLAG binding to DNA.    
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By NSA, we examined PHA-4::YFP association with two PHA-4 targets. 
One was M05B5.2, which is broadly expressed in pharyngeal cells from the pre-
bean stage; the other target was ceh-22, which is activated specifically in a 
subset of pharyngeal muscles from the bean stage (Figure 2.5 and Figure 2.6) 
(Gaudet and Mango, 2002). At the 8E stage, before the active transcription of 
either M05B5.2 or ceh-22, we observed PHA-4::YFP association with the 
M05B5.2 and ceh-22 promoters on the arrays (Figure 2.5B and Figure 2.6B). The 
levels of PHA-4::YFP association with arrays were variable in individual analyzed 
pharyngeal nuclei. On average, there was around 10% of total PHA-4::YFP 
bound to arrays containing the M05B5.2 or ceh-22 promoters at the 8E stage. At 
later embryonic stages, higher levels of PHA-4::YFP association with arrays were 
detected in more pharyngeal cells. This observation suggests an increase of 
PHA-4::YFP binding to target promoters during embryogenesis. 
To verify the early PHA-4 binding to pharyngeal promoters for 
endogenous genes, we performed ChIP to detect PHA-4 binding to the cis-
regulatory regions of M05B5.2, ceh-22, and myo-2 (also a pharyngeal muscle 
target expressed at late embryonic stages (i.e., ≥ 2-fold)). Similarly, ChIP-qPCR 
by both GFP and FLAG antibodies showed PHA-4::GFP::3xFLAG association 
with all three tested pharyngeal genes at the 8E stage, before transcriptional 
activation  (Figure 2.7A  and Figure  2.7B). These two approaches revealed that 
PHA-4 bound to pharyngeal targets earlier before those genes generate mature 
mRNA.  
 




Array with lower PHA-4 affinity has reduced PHA-4 binding and is 
compacted in early stages. (A) Chosen promoter for NSA. PCR amplified 430 
bp M05B5.2 promoters containing a wild type high affinity PHA-4 binding site or a 
mutated low affinity site (Down mutation) were used for NSA. (B) Measurement 
of the proportion of PHA-4::YFP binding to the arrays carrying M05B5.2 
promoters with high (WT) or low (Down) affinity PHA-4 sites (X axis) and the size 
of the arrays (Y axis). NSA was performed by capturing live images of embryos 
from 8E to 2-fold and analyzed using Volocity imaging software. (C) Temporal 
expression of PM05B5.2::GFP. M05B5.2-WT (high affinity) promoter activated 
GFP reporter at pre-bean whereas M05B5.2-Down (low affinity) promoter 
delayed GFP expression at 2-fold (Gaudet and Mango, 2002). 
 
 




Increased binding site affinity enhances PHA-4 binding and is associated 
with the appearance of a decompacted array at early stages. (A) Chosen 
promoter for NSA. PCR amplified 373 bp ceh-22 promoters containing either a 
wild type low affinity PHA-4 binding site or a mutated high affinity site (Up 
mutation) were used for NSA. (B) Measurement of the proportion of PHA-4::YFP 
binding to the arrays carrying the ceh-22 promoter with low (WT) or high (Up) 
affinity PHA-4 sites (X axis) and the size of the arrays (Y axis). The NSA was 
performed by capturing live images of embryos from 8E to 2-fold and data were 
analyzed using Volocity imaging software. (C) Temporal expression of Pceh-
22::GFP. The ceh-22-WT (low affinity) promoter activated the GFP reporter at 
bean whereas the ceh-22-Up (high affinity) promoter advanced GFP expression 
at pre-bean (Gaudet and Mango, 2002). 
 
 















PHA-4 binding affinity reflects the level of PHA-4 occupancy at endogenous 
targets. (A) PHA-4 binding to endogenous targets was detected by PHA-4::GFP 
ChIP in 8E embryos. (N > 3) (B) PHA-4::FLAG ChIP in 8E embryos. (N = 3) (C) 
PHA-4::FLAG ChIP in bean embryos. (N = 3) M05B5.2 and myo-2 contain high 
affinity PHA-4 binding site. ceh-22 pro and ceh-22 TSS contain low affinity PHA-4 
binding sites previously identified (Gaudet and Mango 2002). The ceh-22 intron 2 
contains a PHA-4 binding element with unknown affinity identified from 
modENCODE research (Zhong et al. 2010). ceh-22 intron 1, taf-1 pro, and taf-1 
control 2 regions contain no PHA-4 binding sites and served as negative 
controls. N2 without a tagged PHA-4 was used as the wild type strain. The 
SM2078 strain expresses integrated pha-4::gfp::flag in a pha-4 mutant 
background.  
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2.4.4 Binding site affinity affects the level of PHA-4  
occupancy at target promoters 
Previous studies from our lab indicate that the temporal control of 
pharyngeal expression is fine-tuned by PHA-4 binding site affinity within the 
target promoters (Gaudet & Mango, 2002). PHA-4 was able to bind to different 
target genes before active transcription as determined by NSA and ChIP. We 
hypothesized that binding site affinity might impact the level of PHA-4 occupancy 
at target promoters. For instance, the M05B5.2 promoter and ceh-22 promoter 
contain high and low affinity binding sites, respectively, which were previously 
shown to be important for temporal pharyngeal expression (Gaudet and Mango, 
2002). In vitro binding assay indicated that low affinity PHA-4 binding sites (such 
as PHA-4 site in the ceh-22 promoter) had 2–5-fold less affinity for PHA-4 than 
did high affinity sites (Gaudet and Mango, 2002). Within the promoter context, we 
generated a “down mutation” in M05B5.2 promoter to lower the PHA-4 binding 
site affinity and an “up mutation” in the ceh-22 promoter to increase PHA-4 
binding affinity in a range of 2–5-fold (Figure 2.5A and Figure 2.6A). These 
mutations of PHA-4 affinity sites in the promoter context resulted in shifting the 
onset of M05B5.2 and ceh-22, as evidenced by the expression of promoter-fused 
GFP reporters. Specifically, the down mutation to lower PHA-4 binding site 
affinity within M05B5.2 promoter caused a delayed GFP expression at the 2-fold 
stage, which is around 6 hours later in development compared to normal onset at 
the pre-bean stage (Gaudet and Mango, 2002). To explore the molecular 
mechanism of PHA-4-controlled temporal gene expression through binding site 
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affinity, we employed NSA to visualize PHA-4 binding to extrachromosomal 
arrays carrying target promoters with different PHA-4 affinity sites. We generated 
strains carrying extrachromosomal arrays with either wild type or a down/up 
mutation of these PHA-4 target promoters. We matched the strains that bore 
similar copy numbers of wild type versus mutant PHA-4 target promoters on the 
arrays in which the available PHA-4 binding sites are equivalent between two 
compared NSA strains.  We further matched the stains expressing similar levels 
of pha-4::yfp so that we could better examine the effect of affinity on PHA-4 
binding to target promoters. We measured the level of PHA-4 binding by 
quantifying the proportion of PHA::YFP colocalized with LacI::CFP (Figure 2.4C). 
Comparing wild type M05B5.2 promoter with its down mutation, more PHA-
4::YFP was enriched at the array carrying the high affinity PHA-4 binding site, 
especially at early embryonic stages from the 8E to comma stages (P < 0.05) 
(Figure 2.5B). We also observed slightly increased PHA-4::YFP binding when the 
wild type low affinity site within ceh-22 promoter was mutated to a high affinity 
site. However, PHA-4::YFP binding to the wild type ceh-22 promoter and its up 
mutation only showed a difference at the 8E and pre-bean stages (P < 0.05) but 
not at later stages (Figure 2.6B). This NSA result suggests that changing PHA-4 
binding site affinity affects the level of PHA-4 association with target promoters. 
The effect of binding affinity on PHA-4 association is variable between different 
PHA-4 targets.  
Previous studies of PHA-4 and its orthologous FoxA factors indicate that 
PHA-4/FoxA influences the chromatin environment after binding to its targets 
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(Cirillo et al., 2002; Kiefer et al., 2007; Updike and Mango, 2006). Using a similar 
NSA set-up, we have shown that PHA-4 binding to its target promoters results in 
chromatin decompaction (Fakhouri et al., 2010). To extend this finding, we tested 
whether binding site affinity plays a role in PHA-4 affected chromatin 
decompaction by measuring the intensity of LacI::CFP to determine the array 
size. In the pharyngeal nuclei, we observed a positive correlation of the levels of 
PHA-4::YFP binding and decompacted array morphology indicated by the 
increase of array size. When we compared arrays carrying M05B5.2 promoters 
with different affinity sites at the same embryonic stages, we found that the 
arrays with wild type high affinity PHA-4 sites tend to have more PHA-4 binding 
and are associated with more decompacted array morphology (Figure 2.5B). The 
down mutation of M05B5.2 promoter resulted in a less decompacted chromatin 
at early embryonic stages that might restrain productive transcription and cause 
delayed onset of gene expression. Overall, our NSA data suggest that changing 
PHA-4 binding site affinity affects the level of PHA-4 association with target 
promoters and PHA-4 binding induced chromatin decompaction. The affinity 
effect is more pronounced at early embryonic stages and variable depending on 
the different pharyngeal promoters used.   
To further investigate the effect of affinity on PHA-4 binding at 
endogenous targets, we performed ChIP in synchronized early (8E) and later 
(bean) embryos. From PHA-4 ChIP at the 8E stage, both PHA-4-GFP and PHA-
4-FLAG ChIP assays showed a similar trend but different scales in which PHA-4 
occupancy was higher at high affinity targets, M05B5.2 and myo-2, compared to 
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the low affinity target, ceh-22 (Figure 2.7A and Figure 2.7B). The level of PHA-4 
occupancy was significantly different between high versus low affinity PHA-4 
targets in the GFP ChIP assay (5–10-fold difference) in comparison with a 
slightly increased PHA-4 occupancy at high affinity sites (2–2.5-fold) in FLAG 
precipitation at the 8E stage. Based on the normalization to the input signal, the 
GFP ChIP assay also showed higher levels of precipitation. This difference 
suggests that the anti-FLAG antibody was less efficient in precipitating PHA-
4::GFP::FLAG. Unfortunately, the anti-GFP antibody deteriorated and lost its 
specificity, so we were no longer able to use the anti-GFP antibody to perform 
further ChIP analysis in older embryos. Therefore, we compared whether binding 
site affinity affected PHA-4 occupancy using the anti-FLAG antibody. When PHA-
4 level reaches to a plateau at the bean stage (Figure 2.1B), we still observed 
more PHA-4 binding at high affinity sites (Figure 2.7C). This result suggests that 
affinity continuously affects PHA-4 association with different targets at the bean 
stage. However, the different levels of PHA-4 occupancy at various targets by 
ChIP might be affected by different cell numbers in which the pharyngeal targets 
are expressed (see discussion). For this consideration, we compared the PHA-4 
occupancy between ceh-22 and myo-2, which are both expressed in a similar 
number of pharyngeal muscle cells. The FLAG precipitation showed higher PHA-
4 occupancy at myo-2 (high affinity target) in comparison to ceh-22 (low affinity). 
This result indicates that binding site affinity affects on the promoter occupancy 
of transcription factors at endogenous targets. 
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2.5 Discussion 
 In this study, we investigated the interplay between the level of a 
transcription factor PHA-4 and its DNA binding affinity on the level of promoter 
occupancy and temporal expression of target genes during embryonic 
development. This study provides two insights into understanding the 
fundamental mechanisms of transcriptional regulation. First, we used NSA to 
quantitatively examine the extent to which DNA binding site affinity affected PHA-
4 association to different targets within the promoter context. We found that 
binding site affinity affected the level of PHA-4 occupancy and impacted the 
temporal pharyngeal expression of promoter-fused reporters (Gaudet and 
Mango, 2002). Second, the PHA-4 level is critical to control the onset of 
pharyngeal expression. We tested an affinity model by varying PHA-4 levels and 
examining the transcriptional output. The onset of pharyngeal gene expression 
was normal within a 2–3-fold of changing PHA-4 level but was misregulated 
when PHA-4 level changed dramatically. This observation implies that the 
transcriptional program is faithfully maintained within a range of transcription 
factor concentration. 
 
2.5.1 PHA-4 levels and the onset of pharyngeal expression 
Genetic analysis of pha-4 mutant alleles demonstrated that PHA-4 activity 
is absolutely required for pharynx development (Mango et al., 1994). Reducing 
PHA-4 activity by shifting pha-4(ts) mutant to restrictive temperature at different 
developmental time points indicates that the level of PHA-4 impacts every aspect 
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of pharyngeal development and function (Gaudet and Mango, 2002; Kaltenbach 
et al., 2005). This result suggests that PHA-4 activity is required throughout 
development and PHA-4-regulated pharyngeal expression is sensitive to PHA-4 
dose.  
Interestingly, temporal pharyngeal expression was maintained properly 
within 2–3-fold of increased PHA-4 level when we examined the onset of two 
endogenous pharyngeal genes expression in the PHA-4::GFP strain. This result 
is in agreement with the fact that the heterozygous pha-4/+ animal appears 
normal (Mango et al., 1994) and suggests that the pharyngeal gene expression is 
normally regulated. In contrast, Ppax-1::GFP was precociously expressed when 
PHA-4 level was increased dramatically by heat shock in early embryos (Figure 
2.2). Similarly, the onset of Pceh-22::GFP was delayed when the PHA-4 level 
was dropped to lower than 10% by pha-4 RNAi (Figure 2.3). These data support 
an error tolerance of pharyngeal gene expression in worms, especially the onset 
of expression, within a range of PHA-4 level fluctuation. Different from worms, 
heterozygous Foxa/+ mice have various developmental defects, which suggests 
that a half dose of Foxa is not sufficient to maintain target gene expression (Ang 
and Rossant, 1994; Weinstein et al., 1994). Maintaining a precise and 
reproducible transcriptional outcome with a dynamic range of inputs is important 
for developmental robustness. Perhaps different mechanisms were evolved in 
different organisms to control transcriptional precision. Utilizing various affinity 
binding sites to modulate temporal gene expression might provide an advantage 
to respond to dynamically changing PHA-4 levels during development. This 
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explanation supports the conclusion that the effect of affinity on PHA-4/FoxA- 
regulated gene expression is more emphasized in C. elegans than other 
organisms.    
In addition to the level of PHA-4, the timing in response to PHA-4 activity 
is also crucial to set up temporal pharyngeal gene expression. It has been shown 
that the early embryonic stage between the 2E to 8E stages is a critical time 
window for cells to respond to developmental regulators, such as PHA-4, and 
acquire pharyngeal fates (Kiefer et al., 2007). From pha-4 heat shock 
experiments, the onset of Ppax-1::GFP was advanced and ectopically expressed 
when pha-4 was induced between the 2E to 8E stages but not later stages. 
Based on our observation and previous studies, the data suggest that 
maintaining proper PHA-4 levels during early embryogenesis specifically during 
the 2E to 8E stages is important to set up proper temporal pharyngeal 
expression.  
 
2.5.2 PHA-4 binding affinity and pharyngeal promoter  
occupancy 
To understand how binding site affinity affects transcription factor 
association with target promoters, we explored PHA-4 occupancy at pharyngeal 
targets from various angles. First, does changing PHA-4 binding site affinity 
within the promoter context affect the level of PHA-4 binding? Previously, the 
research from our lab reported that changing PHA-4 affinity within the promoter’s 
own architecture affects its temporal pharyngeal expression (Gaudet & Mango, 
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2002). In a similar setting, we examined whether the advanced or delayed 
pharyngeal expression was caused by increased or decreased PHA-4 occupancy 
at pharyngeal promoters. Using the NSA, the M05B5.2 down mutation, which 
was shown to cause delayed pharyngeal expression (Gaudet and Mango, 2002), 
indeed showed a decrease in PHA-4 binding compared to a wild type promoter 
containing a high affinity PHA-4 site. The effect of affinity on PHA-4 binding to 
M05B5.2 was most dramatic at early embryonic stages. Surprisingly, the effect of 
affinity on PHA-4 binding to the ceh-22 promoter was not significant. Slight 
differences in PHA-4 occupancy at ceh-22 wide type (low affinity) and ceh-22 up 
mutation (high affinity) were observed at the 8E and pre-bean stages but not later 
stages. 
One possible explanation is the difference of chromatin organization at 
early versus late embryonic stages. Studies from our lab and others have shown 
that chromatin is generally open and accessible during early embryogenesis in C. 
elegans (Fakhouri et al., 2010; Meister et al., 2010; Yuzyuk et al., 2009). 
Therefore, perhaps PHA-4 binding sites are more accessible to PHA-4 binding 
during early embryogenesis, leading to a more pronounced effect of affinity at 
early stages. The feature of accessible, decompacted chromatin environment 
during early embryogenesis supports the early binding of PHA-4 to its targets as 
we observed with NSA and ChIP.  
Based on the effect of affinity observed from NSA, how did PHA-4 
occupancy correlate to different affinities among different endogenous 
pharyngeal targets? PHA-4 ChIP was performed in whole embryos containing 
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both pharyngeal cells and other cell types. In addition, pharyngeal targets were 
differentially expressed in either whole pharyngeal cells or a subset of the 
pharyngeal population. Therefore, it was necessary to take into account the 
number of pharyngeal cells contributing to the PHA-4 signal at individual 
pharyngeal promoters. When comparing the PHA-4 occupancy at two pharyngeal 
muscle targets expressed in a similar number of cells, ceh-22 and myo-2, ChIP 
showed that the level of PHA-4 occupancy correlated with affinity. The PHA-4 
occupancy was 2–5-fold higher at myo-2 (high affinity site) than at ceh-22 (low 
affinity site, specifically in region of ceh-22 TSS detected by ChIP-qPCR, which 
contains a low affinity site previously identified) at the 8E and bean stages. This 
result matched the in vitro binding affinity of PHA-4 sites measured previously 
(Gaudet and Mango, 2002). Accordingly, PHA-4 occupancy at M05B5.2 that 
expressed broadly in whole pharyngeal cells showed a 3-fold increase as the 
number of pharyngeal cells increasing from 8E to bean. Compared to myo-2 and 
ceh-22 that only expressed in pharyngeal muscle cells (37 cells at the bean 
stage), M05B5.2 showed the highest PHA-4 occupancy at bean stage (94 cells). 
This result suggests that both binding site affinity and the cell numbers 
contributed to the difference of PHA-4 occupancy at various pharyngeal targets 
detected by ChIP. After carefully examining the differences in cell numbers 
contributing to the ChIP signal at various PHA-4 targets, we concluded that 
binding site affinity affected the level of PHA-4 occupancy at endogenous targets.  
In summary, we have shown that PHA-4 bound its targets before active 
transcription. The PHA-4 affinity sites within the target promoters affected the 
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level of PHA-4 occupancy. The difference in PHA-4 occupancy at pharyngeal 
promoters further modulated the temporal expression during pharynx 
development. The proposed affinity model predicts that PHA-4-regulated gene 
expression is sensitive to PHA-4 concentration as we observed in pha-4 RNAi 
and pha-4 heat shock experiments. Expanding beyond individual pharyngeal 
gene studies, it will be insightful to examine the genome-wide temporal PHA-4 
binding patterns at endogenous loci. The genome-wide study of temporal PHA-4 
binding will expand our understanding about binding site affinity involved global 
gene regulation during organogenesis.  
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TEMPORAL POISED RNA POL II DURING C. ELEGANS  
EMBRYOGENESIS: A POTENTIAL ROLE OF  
PHA-4/FOXA TO REGULATE POL II 
 
Chapter 3 is a project that will be submitted for publication after additional 
experiments are completed. Authors are Hui-Ting Hsu and Susan Mango. 
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3.1 Abstract 
Recent studies of genome-wide Pol II occupancy in various organisms 
and developmental contexts revealed that RNA Pol II is pervasively poised at 
promoter proximal regions. Therefore, two aspects of gene regulation are 
suggested: the specific recruitment of Pol II and the control of productive 
elongation by Pol II at target genes which are regulated by sequence specific 
transcription factors in the course of development. As studies of poised Pol II in 
flies and mammals reveal its important role in regulating differential gene 
expression, Pol II poising in worms is still largely unknown. To determine whether 
Pol II is poised during early embryogenesis in C. elegans, we performed Pol II 
ChIP-Seq to examine the genome-wide Pol II occupancy in synchronized 
embryos at early and mid-embryonic stages. Temporal Pol II ChIP-Seq revealed 
at least four different patterns of Pol II occupancy that reflected the transcriptional 
status of genes. Moreover, we identified additional genes, including a subset of 
pharyngeal specific genes that were specifically poised at different embryonic 
stages, which suggests that Pol II poising is temporally regulated. Interestingly, 
promoter occupancy of Pol II at poised pharyngeal genes was greatly decreased 
when PHA-4 was eliminated, indicating that PHA-4 activity is required to load Pol 
II at a subset of pharyngeal genes. We hypothesize that PHA-4/FoxA functions 
as a pioneer factor and primes gene activation partly through affecting temporal 
Pol II occupancy at pharyngeal promoters. These results suggest that other Fox 
factors, perhaps also other selector genes, might function similarly to control 
gene expression through regulation of Pol II poising.   
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3.2 Introduction 
The regulation of RNA polymerase II plays a central role in controlling 
differential gene expression during development, including organogenesis. The 
specificity of gene expression required for developmental processes is governed 
by sequence specific transcription factors, such as selector genes that can 
control a cohort of genes responsible for forming organs or specifying tissue 
types (Mann and Carroll, 2002). The traditional view of transcriptional control of 
gene expression involves the recruitment of RNA Pol II to specific promoters. 
The recent discovery that Pol II pervasively paused at promoter proximal regions 
in various organisms reveals another layer of transcriptional control (Muse et al., 
2007; Rahl et al., 2010; Zeitlinger et al., 2007). These studies suggest two tiers of 
regulation, specific recruitment of Pol II and control of Pol II productive elongation 
at target genes. Sequence specific transcription factors could regulate either or 
both steps to modulate gene expression in response to development. 
RNA Pol II is recruited to genes to form a preinitiation complex (PIC), an 
event that is aided by some transcription factors. For example, some 
transcription factors recruit histone modifiers and chromatin remodelers resulting 
in decompaction of chromatin to facilitate recruitment of general transcription 
factors and RNA Pol II. For example, MyoD binding to the myogenic targets 
recruits p300 histone actyltransferase and switch/ sucrose nonfementable 
(SWI/SNF) chromatin-remodeling complexes to create a permissive chromatin 
environment for PIC assembly (Forcales, 2012; Puri et al., 1997; Simone et al., 
2004). Studies with the Myogenin promoter have found that MyoD directly 
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interacts with the cell-type-specific TATA binding protein (TBP) associated factor 
(TAF) TAF3/TRF3 to assemble the PIC for Myogenin activation (Deato et al., 
2008). These findings indicate that sequence-specific transcription factors can 
directly interact with general transcription factors (GTFs) (Fuda et al., 2009). 
However, the order of the recruitment to build the PIC during transcriptional 
initiation is still not clear. The establishment of transcriptional initiation might be 
dependent on the context of the promoters and associated activators rather than 
on a fixed sequence of steps (Morse, 2007). 
On the other hand, sequence-specific transcription factors can also control 
gene expression through the release of paused Pol II. p-TEFb, composed of 
cyclin-dependent kinase 9 and cyclin T, is required for the transition from 
transcriptional initiation to productive elongation (Zhou et al., 2012). Various 
sequence-specific transcription factors interact with p-TEFb to promote 
elongation, including NF-κB (Barboric et al., 2001), androgen receptor (Lee et al., 
2001), Myc (Eberhardy and Farnham, 2002; Rahl et al., 2010), MEF2 (Nojima et 
al., 2008), and MyoD (Giacinti et al., 2006). Among these reported transcription 
factors, MyoD in mammals is a selector gene that regulates target gene 
expression at both transcriptional initiation and productive elongation steps to 
control skeletal myogenesis. Besides MyoD, forkhead factors in yeast have been 
implicated to coordinate pre-mRNA processing through promoting transcriptional 
elongation (Morillon et al., 2003). The role of selector genes in regulation of 
transcriptional elongation still waits to be explored.   
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Although Pol II pausing is implicated as a mechanism to control gene 
expression, how is paused Pol II established prior to gene activation at specific 
promoters? Sequence-specific transcription factors likely play a role in this 
process to provide specificity. GAGA factor binding to the GAGA motif, which is 
enriched at paused promoters in Drosophila embryos (Lee et al., 2008), is 
thought to recruit chromatin-remodeling complexes and interact with transcription 
factor II D (TFIID) to maintain an open chromatin environment suitable for 
establishing paused Pol II (Adkins et al., 2006; Leibovitch et al., 2002). Removing 
the GAGA motif within a paused promoter did not inhibit gene activation but did 
eliminate 5’ enriched Pol II pausing (Wilkins and Lis, 1997). However, GAGA 
factor only accounts for about 20% of paused genes in Drosophila embryos (Lee 
et al., 2008), which suggests other factors are required for establishing Pol II 
pausing at promoters without the GAGA motif. Supporting this idea, no obvious 
GAGA factor has been found in worms or mammals, despite the existence of 
poised Polymerase in these organisms (Gilmour, 2009).  
Pioneer factors are a potential candidate to establish paused Pol II. 
Pioneer transcription factors are unique based on their capability to bind target 
DNA within a compacted chromatin before gene activation (Cirillo et al., 2002; 
Zaret and Carroll, 2011). In particular, FoxA factors in mammals have been long 
thought to function as a pioneer factor with the ability to bind the albumin alb1 
enhancer when the chromatin is still compacted, before albumin expression. The 
binding of FoxA to the alb1 enhancer in vitro promotes decompaction of 
chromatin that is sensitive to DNase (Cirillo et al., 2002). Moreover, the binding of 
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FoxA enables subsequent binding of other factors, such as estrogen receptor 
(ER), which has been shown in different cell types (Carroll et al., 2005; Lupien et 
al., 2008; Zhang et al., 2005). Studies from FoxA factors suggest that pioneer 
factors can function actively to facilitate access of additional factors, such as 
assembly of the general transcription machinery. Thus, FoxA serves as a good 
candidate to test if pioneer factors also function to recruit or set up Pol II at 
specific promoters. 
In Drosophila, a maternal Zinc finger transcription factor, Zelda, is 
essential for gene activation during maternal-zygotic transition (Liang et al., 
2008). Zelda binds to a specific cis-element, CAGGTAG that is found at 
promoters and enhancers of many developmental regulators hours before their 
expression (Liang et al., 2008). Zelda binding is highly correlated with association 
of many transcription factors at promoters and enhancers genome-wide (Satija 
and Bradley, 2012), which supports a model that Zelda facilitates the recruitment 
of other transcription factors to promote zygotic transcription. The early binding of 
Zelda to target genes in preparation of later expression suggests Zelda is a 
pioneer factor. In addition, about one-third of Zelda target genes are highly 
paused in early Dosophila embryos (Saunders et al., 2013). To understand how 
Zelda target genes are regulated, Saunders and colleagues performed GRO-Seq 
at two time points during early embryogenesis in fly embryos. Their data 
indicated that Zelda-bound targets were regulated via both recruiting Pol II and 
releasing paused Pol II, suggesting Zelda does not regulate transcription at the 
recruitment step, at least not exclusively (Saunders et al., 2013). However, no 
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one has yet examined whether Zelda is required to recruit Pol II to promoters or 
to facilitate elongation, using mutant analysis. 
The C. elegans FoxA homolog, PHA-4 has been implicated to function like 
a pioneer factor for foregut formation. PHA-4 binds to pharyngeal targets long 
before the onset of transcription and induces chromatin decompaction partly 
through recruitment of histone variant H2AZ/HTZ-1 (Fakhouri et al., 2010; Updike 
and Mango, 2006). Although Pol II ChIP-Seq and GRO-Seq experiments 
suggested that only 2% or fewer genes exhibited stalled Pol II in mixed-stage 
embryos, PHA-4 binding clearly overlapped with 85% of Pol II stalled genes in 
embryos (Kruesi et al., 2013; Zhong et al., 2010). This result reveals a correlation 
between PHA-4 binding and Pol II poising.  
Genome-wide Pol II occupancy in C. elegans has been performed in 
mixed-stage embryos. Due to the heterogeneity of stages, the Pol II signal at 
each gene is contributed from nuclei with different states of transcriptional 
activity. This heterogeneity makes it difficult to uncover the patterns of Pol II over 
time. An ideal experiment would be to analyze Pol II signal within nuclei of a 
homogeneous population of one cell type at one stage of development. However, 
the lack of C. elegans cell lines and the large quantity of chromatin required for a 
single ChIP experiment make this goal unattainable. In Drosophila, poised Pol II 
at developmental genes during early embryogenesis was not restricted to one 
particular cell type (Zeitlinger et al., 2007), suggesting that the ideal experiment 
may not be essential to characterize Pol II poising in development. However, the 
dynamics that have been observed in Drosophila embryos and C. elegans larvae 
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(Baugh et al., 2009; Gaertner et al., 2012) suggest that staged embryos would be 
important to track poising during embryogenesis.  
To investigate whether Pol II poising is happening during early 
embryogenesis in C. elegans, I collected stage-specific embryos for Pol II ChIP-
Seq. Pol II occupancy was analyzed at the 8E stage (an early embryonic stage) 
and at the bean stage (a midembryonic stage) to examine the Pol II dynamics 
before and after different gene expression.     
PHA-4 activity is absolutely required to control pharyngeal gene 
expression both early during specification and later during differentiation (Mango, 
2009). The features of early binding of PHA-4 to pharyngeal targets and the 
induction of open chromatin suggest that PHA-4 might recruit Pol II or establish 
the chromatin configuration to promote Pol II poising before gene activation. I 
tested this hypothesis by examining Pol II occupancy at pharyngeal targets in 
wild-type and pha-4 mutant embryos.  
 
3.3 Materials and methods 
3.3.1 Strains and growth condition 
Strains were provided by the Caenorhabditis Genetics Center and 
maintained at 20°C, except for the stated strains. Bristol N2 was used as a wild 
type strain. SM190 smg-1(cc546ts)I;pha-4(zu225)V and SM568 smg-1(cc546ts)I; 
pha-4(q500) rol-9(sc148)V were maintained at 24°C (permissive temperature) 
and shifted to 15°C (restrictive temperature) for experimental tests as previously 
described (Gaudet and Mango, 2002; Kaltenbach et al., 2005). 
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3.3.2 Embryo staging and crosslinking 
To collect stage-specific wild type N2 embryos, starved L1 larvae from 4–5 
6 cm OP-50 plates were washed and grown in 250 mL S medium with NA22 as a 
food source and incubated at 20°C with 200 rpm shaking until worms were 
gravid. The worms were then bleached to collect embryos. Embryos were 
transferred to 100 mL S medium without food to obtain a synchronized L1 larval 
population. The L1 larvae were then transferred to S medium with concentrated 
NA22 to grow at 20°C at 200 rpm shaking. Worms were harvested and bleached 
after proximately 56–60 hours incubation, when young adult worms have only 1–
2 fertilized embryos in the gonads. After bleaching the worms, most of the 
embryos harvested contained 1–4 cells embryos. The embryos were suspended 
in 1mL M9 buffer and put on a NGM plate without food to age to the desired 
developmental stages. The 1–4 cells embryos were incubated at 20°C for 3 to 
3.5 hours to reach the 8E stage, 5–6 hours to the bean stage and 8–10 hours to 
the 2-fold stage. The aged embryos were washed to harvest and spun down. The 
embryo pellets were flash frozen in liquid nitrogen following thawing on ice for 
one cycle to crack the eggshell. The embryos were cross-linked by adding 900 
uL 1.5% formaldehyde in M9 and incubating for 30 minutes with rotation. 100 uL 
of 1.25M glycine was added and incubated for 5 minutes to quench the excess 
formaldehyde. The embryo pellets were then washed 3 times with cold M9 with 
protease inhibitors (CalBiochem Protease Inhibitor Cocktail Set 1). After the 
wash, the embryo pellets were ready for ChIP. 
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For collecting pha-4(ts) mutant embryos, SM190 were grown on 10 large 
10 cm plates with HB101 as a food source and maintained at 24°C for two and 
half days until worms were gravid. The worms were then bleached to collect 
embryos. Embryos were transferred to a large 10 cm NGM plate without food to 
obtain a synchronized L1 larval population. The L1 larvae were then transferred 
to 10 cm plates seeded with HB101 bacteria at a density of 50,000 L1 per large 
plate. After growing at 24°C for around 40 hours, the majority of worms were L3 
to L4 stage. At this point, pha-4(ts) worms were shifted to 15°C and incubated 
overnight. Worms were harvested and bleached when young adult worms had 1–
4 fertilized embryos in the gonads; most of the embryos harvested contained 1–8 
cells embryos. The embryos were suspended in 1 mL M9 buffer and put on an 
NGM plate without food and aged to the desired developmental stages. 1–8 cells 
embryos were incubated at 15°C for 5–8 hours to achieve a population 
containing embryos from the 8E to bean stages. The aged embryos were 
prepped as wild type embryos for ChIP.  
 
3.3.3 Chromatin immunoprecipitation 
Approximately 300,000 embryos were suspended in 300 uL of lysis buffer 
(50mM Tris pH 8.0, 10mM EDTA pH 8.0, 0.2% SDS, 1x complete EDTA 
protease inhibitor, 1x PhosStop) and incubated on ice for 30 minutes. Using a 
QSonica Q700 Sonicator, the samples were sonicated at the following settings: 
80% amplitude, 30 seconds on, 30 seconds off, and 20 cycles. After sonication, 
the extract was spun down for 15 minutes at 14,000 rpm at 4°C to remove the 
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debris. The supernatant was transferred to new tubes. Chromatin concentration 
was measured by Nanodrop and 50ug of chromatin was used per ChIP reaction. 
50 ug of chromatin was diluted in ChIP dilution buffer (0.01% SDS, to 1.1% Triton 
X-100, 1.2mM EDTA, 16.7mM Tris-HCl pH 8.1, 167mM NaCl) to 1 mL and 
precleared for 1 hour at 4°C by protein A agarose beads. 10% of ChIP material 
was saved as input. A commercially available antibody, 4H8 (Covance), was 
used to detect RNA polymerase II. 2 ug of 4H8 antibody was conjugated to 25 uL 
of protein G magnetic beads for at least 6 hours at 4°C prior to ChIP. The 
immunocomplexes were then incubated at 4°C on a rotator for 15–17 hours. 
After incubation, beads were washed twice with ChIP dilution buffer, twice with 
low salt buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl pH 8.1, 
150mM NaCl), twice with high salt buffer (0.1% SDS, 1% Triton X-100, 2mM 
EDTA, 20mM Tris-HCl pH 8.1, 500mM NaCl), once with LiCl buffer (100mM Tris 
pH 8.0, 500mM LiCl, 1% deoxycholic acid, 1% NP-40), and three times with TE 
buffer (10mM Tris pH 8.0, 1mM EDTA pH 8.0) for 5 minutes on the rotator. 1 mL 
of buffer was used in every wash and briefly vortexed for 10 seconds before 5 
minutes incubation on the rotator. To elute the bound immunocomplexes, 150 uL 
of elution buffer (50mM NaHCO3, 140mM NaCl, 1% SDS) was added to each 
tube and heated at 55°C for an hour with vortexing every 5 to 10 minutes. From 
this point, the ChIP input samples were then treated the same to release DNA. 
Brifely, 1uL of RNaseA (200 mg/mL) was added to each tube followed by 
incubation at 37°C for 30 minutes. To reverse cross-links, 2 uL of protease K (10 
mg/mL) were added and incubated at 65°C overnight. The released DNA was 
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purified using a Qiaquick PCR purification kit (Qiagen) and eluted twice with 50 
uL of elution buffer. For sequencing library construction, the DNA was purified 
and concentrated using a MinElute Reaction Cleanup Kit (Qiagen) and eluted 
twice with 10 uL of elution buffer. Both input DNA and ChIP DNA was loaded in a 
2% low melting agarose gel to select fragment sizes lower than 500 bp before 
performing quantitative PCR.  
 
3.3.4 Quantitative PCR 
For quantification of ChIP signals and gene expression, specific primers 
against genomic regions of PHA-4 targets, positive control (eft-3) and negative 
control (SRW-99 and SRW-96) were used to detect Pol II occupancy and RNA 
expression. Each primer set (see Table A.1 for primer sequences) was calibrated 
by a standard curve using multiple dilution of template DNA isolated from cross-
linked and sonicated chromatin to quantify the enrichment of binding relative to 
the input signal. For our experiment, KAYA SYBR Fast Universal QPCR Kit was 
used (KAPA Biosystems Cat# KK4602).  
 
3.3.5 Library preparation for illumina sequencing 
The ChIP-Seq libraries from two 8E stage Pol II ChIP and one bean stage 
Pol II ChIP were generated by using Apollo 324 System and PrepX ILM DNA 
Library Kit from IntergenX. After adaptor ligation, the input and ChIP DNA were 
enriched by PCR amplification using Phusion DNA Polymerase (New England 
Biolab) and Illumina universal PCR primer with the following PCR conditions: 30 
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seconds at 98°C, [10 seconds at 98°C, 30 seconds at 65°C, and 30 seconds at 
72°C] for 5 cycles following 5 minutes at 72°C (14 uL adaptor ligated DNA, 15 uL 
NEBNext High-Fidelity 2X PCR master Mix, 1uL Universal PCR primer) (all 
reagents were included in NEBNext ChIP-Seq Library Prep Mix Set for Illumina 
[New England Biolab Cat# E6240S]). The enriched DNA was then purified using 
30 uL (1:1 ratio of DNA volume and beads) of AMPure XP beads (Beckman 
Coulter) and selected 150–600 bp DNA by gel extraction. The size-selected DNA 
was amplified again using the same PCR conditions to amplify 5 more cycles (10 
cycles total) for input libraries and 10 more cycles (15 cycles total) for ChIP 
libraries. After PCR, the libraries were purified by 50 uL (1:1 ratio of DNA volume 
and beads) and AMPure XP beads and eluted with 20 uL of TE buffer. 1 uL of 
each library was applied to measure the concentration using a Qubit dsDNA 
assay kit (Invitrogen). 1 ng of DNA from each library was checked by a 
Bioanalyzer (Agilent Technologies). Input and ChIP libraries were pooled such 
that they each had the same amount of molecules and expected for obtaining the 
similar number of reads. The Illumina sequencing was performed with 50 nt 
paired-end reads for two 8E stage samples and 100 nt paired-end reads for the 
bean stage sample.  
 
3.3.6 ChIP-Seq data analysis 
Raw data of ChIP-Seq from Illumina HiSeq 2000 were quality-checked 
using FastQC. The sequence reads were aligned to the ce10 version of the C. 
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elegans genome, obtained from the UCSC Genome Bioinformatics Site. Further 
filtering was performed to obtain uniquely mapped reads and remove duplicates. 
To determine 5’ poised Pol II, the poising index (PI) was calculated by the 
ration of mean ChIP-Seq reads in the promoter divided by the mean ChIP-Seq 
reads in the gene body for genes >1kb. Promoter Pol II signal was determined by 
Pol II peak found at 50 bp downstream or 250 bp upstream of a newly annotated 
TSS (Chen et al. 2013; Saito et al. 2013). A P-value of 0.05 was applied as a 
cutoff to define Pol II peaks.  
 
3.3.7 RNA isolation and reverse transcription 
For total RNA extraction, frozen embryo pellets were crushed by adding 
equal volume of glass beads (Sigma Cat # G8772-100G) and resuspended in 
Trizol Reagent (GibcoBRL), followed by chloroform extraction. RNA was 
precipitated with isopropanol and washed with 70% ethanol. Extracted RNA was 
treated with DNase before measuring concentration and checking the A260/A280 
ratio using a Nanodrop spectrophotometer.   
Reverse transcription was performed using a ProtoScript M-MuLV First 
Strand cDNA Synthesis Kit (New England Biolabs). 1 ug of extracted RNA and 
random hexamers were used to generate total cDNA. 4 ug of extracted RNA and 
strand specific primers were used to reverse transcribe strand specific 
transcripts. After reverse transcription, samples were treated with RNaseH and 
purified using a QIAquick PCR Purification Kit (QIAGEN). 
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3.4 Results 
 The motivation behind this study was to probe temporal Pol II occupancy 
during embryogenesis in order to understand if RNA Pol II is poised at early 
embryonic stages in C. elegans embryos and how the organ selector gene, PHA-
4/FoxA, might play a role in regulating gene expression by affecting Pol II 
occupancy. 
 
3.4.1 Different patterns of Pol II occupancy in C. elegans  
embryos 
To study Pol II association during development, I analyzed genome-wide 
Pol II occupancy at different embryonic stages in wild type C. elegans embryos. 
We are specifically interested in the dynamics of Pol II occupancy at pharyngeal 
targets that are temporally expressed during pharynx development. Therefore, I 
performed Pol II ChIP-Seq using synchronized wild type 8E (before the 
pharyngeal primordium is formed) and bean (after the pharyngeal primordium is 
formed) embryos. Taking advantages of the published modENCODE data, which 
contain genome-wide Pol II occupancy in mixed mid- to late embryos with most 
embryos older than the bean stage, I confirmed that my ChIP was working 
properly and also tracked Pol II occupancy at 3 distinct phases—early, mid-, and 
late of embryogenesis. The 8E and bean Pol II ChIP-Seq were performed with 50 
nucleotide (nt) paired-end and 100 nt paired-end reads of Illumina sequencing, 
respectively. 
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From both 8E and bean Pol II ChIP-Seq, I observed at least 4 different 
patterns of Pol II occupancy across the whole genome. (1) Silent or inactive 
genes had no or very few reads of Pol II signal across genes. (2) Active genes 
had Pol II occupancy across their entire genes. (3) Poised genes had Pol II 
enriched at their 5’ promoter proximal regions. (4) Internal or 3’ poised genes had 
Pol II occupancy within gene bodies particularly at the 3’ regions of genes (Figure 
3.1). This latter category of gene differed from active genes in that there was little 
to no Pol II signal at the 5’ end. 
To localize Pol II within genes, we needed to map its position relative to 
the TSS. C. elegans is unusual because it employs trans-splicing to generate 
mature mRNAs (Blumenthal, 2012). Primary transcripts are often spliced to 
leader sequences that act as the first exon. This feature of worms makes it 
difficult to identify the 5’ ends of genes, which are removed from immature 
transcripts. Recent studies from three labs have assigned real TSS regions to C. 
elegans genes by either employing GRO-Seq with an immunoprecipitation step 
for the capped 5’ mRNA (Kruesi et al., 2013) or by isolating unspliced RNA from 
embryos (Chen et al., 2013) or by nuclear isolation of cooled animals in which 
the splicing machinery is sensitive to cold temperature (Saito et al., 2013). To 
identify genes with poised Pol II, we applied the newly assigned TSS data (Chen 
et al., 2013; Saito et al., 2013; Kruesi et al., 2013) to calculate the Pausing Index, 
in collaboration with Anat Burger and Erel Levine in the Harvard Physics 
Department. The Pausing Index is defined as the ratio of the ChIP-Seq signal in 
the  TSS  divided  by  the  mean  ChIP-Seq  signal  in  the  body of the gene (see  















Figure 3.1  
Different patterns of Pol II occupancy in C. elegans embryos. Pol II ChIP-
Seq performed by Illumina sequencing indentified 4 different patterns of Pol II 
occupancy in C. elegans 8E and bean embryos. (A) No or very low Pol II signal 
was detected at silent genes, such as srw-96. srw-96 is not expressed at 8E and 
bean stages (see Figure 3.2). (B) Pol II signal across the body of genes for active 
genes, such as eft-3. eft-3 is actively expressed at both 8E and bean stages. (C) 
Pol II was enriched at 5’ promoter proximal regions of poised genes, such as 
ceh-22. ceh-22 is expressed from the bean stage onwards (Figure 3.2). (D) Pol II 
was enriched within gene bodies or at the 3’ end of genes, such as myo-2. myo-2 
is not active until the 2-fold stage. modENCODE Pol II ChIP-Seq was from 
www.modencode.org (Zhong et al., 2010). Y axis indicated 3 Pol II ChIP-Seq 
performed in embryos at different stages, the 8E, bean and mixed-late embryos. 
ON: gene expression is active. OFF: gene expression is silent.  
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materials and methods). Using a statistical cut-off of 0.05, we identified 4.6% 
(1069/23410) and 7.2% (1685/23410) of genes were poised at the 8E and bean 
stages, respectively. In comparison to our results, data from modENCODE and 
the Meyer and Lis labs identified 2% and 0.38% of poised genes in mixed-stage 
embryos. GRO-Seq results from the Meyer lab specifically identified paused 
genes in contrast to modENCODE Pol II ChIP-Seq that determined all forms of 
Pol II similar to our approach. The difference of statistical cut-off also affects the 
analysis of poising. We will verify whether we applied a reasonable cut-off by 
checking the Pol II patterns at genes excluded from a stringent cut-off. 
 I concentrated on analyzing poised Pol II on 161 pharyngeal genes 
previously identified (Gaudet et al., 2004). Using the same threshold, 10.5% of 
pharyngeal genes were poised at the 8E and bean embryos. Among the poised 
pharyngeal genes, 12% of genes were specifically poised at the 8E and 35% at 
the bean stage. This result implies that the regulation of poised Pol II varies with 
the developmental stages in C. elegans embryos. The degree of poised genes 
observed for the pharynx is a little higher than the genome as a whole, 
suggesting features of the pharynx may be optimal for poising. Nevertheless, it is 
clear that many genes do not show obvious poising, either because they are 
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3.4.2 The dynamics of Pol II occupancy during development  
reflect the regulation and the status of gene expression 
To confirm our genome-wide ChIP-Seq result of genes exhibiting poised 
Pol II, I chose five pharyngeal targets in the “poised” category and examined 
them by Pol II ChIP-qPCR from 8E embryos. I chose poised pharyngeal genes 
that exhibited different degrees of poised Pol II (we referred to it as poising rank) 
to test the threshold of our analysis. At the 8E stage, four of five poised targets, 
including high and low ranks of poising, shown in ChIP-Seq indeed exhibited 
enriched 5’ Pol II signal in comparison to the gene bodies by ChIP-qPCR (Figure 
3.2 and 3.3). This result supports our analysis using a p value of 0.05 as a cut-
off. A widely expressed gene, inx-3, did not show 5’ enriched Pol II in ChIP-
qPCR. It is possible that inx-3 is not poised in all cell types as substantial Pol II 
signal was detected in the coding region of inx-3 by ChIP-qPCR. The rest of four 
poised genes were specifically expressed in the pharynx determined by in situ 
hybridization (Tabara et al., 1996). Overall, the result of ChIP-qPCR is consistent 
with our finding from ChIP-Seq.  
ChIP-qPCR also confirmed the pattern of internal and 3’ poised Pol II at 
myo-2 identified from ChIP-Seq. This result provides a validation of our Pol II 
ChIP-Seq analysis. 
By comparing the patterns of Pol II occupancy to the gene expression, we 
found that the four different Pol II patterns reflected on the status of gene activity. 
Genes without or with very low reads of Pol II signals were transcriptionally silent 
or  only  expressed in  a few  cells. An  example of  this  configuration  is  srw-96,  














Figure 3.2  
Dynamic Pol II occupancy at ceh-22 loci reflects mRNA expression of ceh-
22. (A) Pol II ChIP-qPCR of wild type 8E embryos with 5’ enriched Pol II at the 
ceh-22 promoter proximal region. (N > 3) (B) Pol II ChIP-qPCR in wild type bean 
stage embryos with Pol II occupancy within the ceh-22 gene body. (N = 3) (C) 
Pol II ChIP-qPCR at ceh-22 in pha-4(ts) mutant 8E-bean embryos. (N = 3) (D) 
qPCR primers target regions at ceh-22. (E) RT-qPCR detected pha-4 and ceh-22 
mRNA in wild type embryos (blue, red panels) but not in pha-4 mutants (green) 
(N = 2). (Pol II at eft-3 / gene promoter was a positive control for Pol II ChIP-
qPCR and srw-99 promoter was a negative control). Pol II occupancy at different 
ceh-22 genomic regions was normalized to eft-3 (set to 1) and srw-99 gene (set 
to 0). pha-4 mRNA expression served as a positive control for both RT-qPCR 
and an indication for embryonic stages since pha-4 expression is increased from 
8E to bean and eliminated in pha-4(ts) at the restrictive temperature.) 
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PHA-4 activity is required for Pol II occupancy at the TSS T06D8.3. (A) Pol II 
ChIP-qPCR in wild type 8E embryos with 5’ enriched Pol II at the T06D8.3 TSS 
(N = 2). (B) Pol II ChIP-qPCR in pha-4(ts) 8E-bean mutant embryos with 
decreased Pol II occupancy at the T06D8.3 TSS (N = 1). (C) qPCR primers 
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a serpentine receptor specifically activated in few neurons, which showed no 
detectable mRNA expression in embryos (Levin et al., 2012) (Figure 3.1A). 
Actively or ubiquitously expressed genes, such as housekeeping genes eft-3 
(translation elongation factor), taf-1 (TATA-binding protein associated factor), and 
his-72 (H3 histone), showed Pol II occupancy across the whole genes (Figure 
3.1B). None of these genes are expressed selectively in the pharynx. 
Genes that exhibited 5’ enriched Pol II at the 8E and/or the bean stages 
were poised for activation later, including ceh-22 and T06D8.3 (Figure 3.1C, 
Figure 3.2, and Figure 3.3). From RT-qPCR analysis, ceh-22 mRNA was not 
detected at the 8E stage but was increased significantly at the bean stage, in 
agreement with published studies (Figure 3.2) (Kuchenthal et al., 2001). I 
observed poised Pol II in the 8E embryos prior to activation and to a lesser 
degree at the bean stage, when ceh-22 is transcribed. Pol II occupancy at ceh-22 
TSS was decreased concomitant with more Pol II detected in the gene body at 
the bean stage, which dropped the poising rank of ceh-22 from 90 (8E) to 307 
(bean). This observation suggests that the poised Pol II at ceh-22 was released 
from 5’ region to gene body as transcription proceeding. The similar trend of Pol 
II dynamics was also shown at tbx-2 (an early pharyngeal muscle gene that is 
expressed at the 12E stage) whose poising rank was descended from 54 (8E) to 
756 (bean). Comparing the change in Pol II occupancy at the 8E and bean 
stages, these data suggest that Pol II is potentially poised at the 5’ end of a 
subset of pharyngeal genes during early embryonic stages. 
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There are pharyngeal genes in the last category containing Pol II peaks 
within gene bodies and 3’ regions of genes. One of them is myo-2, which is not 
produced until late embryogenesis between the 2-fold and the 3-fold stages 
(Tabara et al., 1996). I detected Pol II occupancy within the gene body of the 
myo-2 locus at the 8E stage, when no myo-2 expression was detectable by RT-
qPCR or using a transcriptional reporter (Figure 3.4; Gaudet and Mango, 2002). 
To examine if Pol II signal within myo-2 gene body was associated with a 
transcriptional event, multiple primers were designed to hybridize with sense or 
antisense strands of myo-2 RNA across the myo-2 gene body. I used these 
primers to perform reverse transcription and analyzed the resulting cDNA by 
qPCR. This analysis revealed that antisense myo-2 RNA was expressed at early 
embryonic stages (Figure 3.4), which suggests that the Pol II signal within the 
myo-2 gene body was responsible for the myo-2 antisense transcription. A 
similar pattern of antisense transcription was also found at the ZK816.4 locus, 
another locus that is also expressed at very late embryonic stages (the 3-fold 
stage) (Gaudet and Mango, 2002). 
An appealing, if speculative, hypothesis to explain these data is that 
antisense transcription could block sense transcription at early embryonic stages 
and perhaps also maintain an opened chromatin environment to promote the 
level of expression at later stages. Alternatively, antisense transcription might 
reflect read-through transcription from the upstream gene, given the high density 
of genes within the C. elegans genome. To distinguish between these 
possibilities, the Pol II occupancy within the  intergenic region between the 3’ end  
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Figure 3.4 
Pol II signal within gene body of myo-2 before active transcription possibly 
accounts for the antisense transcription of myo-2. (A) Pol II ChIP-qPCR in 
wild type 8E embryos with Pol II within the myo-2 gene body. (N > 3) (B) RT-
qPCR to detect myo-2 mRNA expression from 8E, bean to 2–3-fold. myo-2 
mRNA is not expressed until 2–3-fold. (N = 2) (C) Strand-specific RT-qPCR to 
detect strand specific myo-2 expression. (N = 2) At 8E and bean, antisense but 
not sense transcription of myo-2 was detected. (D) qPCR primers target regions 
at myo-2. 
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of myo-2 and the 3’ end of the downstream gene will be investigated by ChIP-
qPCR.  
In summary, I detected four configurations of Pol II on C. elegans genes 
that reflected their status of gene expression. Pol II occupancy was dynamically 
regulated during development. Combining Pol II ChIP-qPCR and RNA analysis, 
we discovered that pharyngeal gene expression was regulated in different ways, 
including Pol II poising and antisense transcription.    
 
3.4.3 PHA-4 activity is required for Pol II occupancy at  
pharyngeal targets 
PHA-4 activity is absolutely required to control pharyngeal gene 
expression during pharynx development. However, little is known about how 
pharyngeal transcription is regulated after PHA-4 binds to its targets. To test if 
pha-4 activity affects Pol II occupancy at pharyngeal targets, I performed Pol II 
ChIP-qPCR in a pha-4 temperature-sensitive mutant strain (see materials and 
methods). When pha-4(ts) mutant grows at the restrictive temperature, pha-4 
activity is eliminated and a pharynx fails to form (Kiefer et al., 2007). In pha-4 
mutant embryos at the 8E or bean stages, the 5’ Pol II occupancy at ceh-22 and 
T06D8.3 (Figure 3.2C and Figure 3.3B) and K10D3.4 (data not shown) was 
decreased when compared to wild type undergoing a similar temperature shift. 
This result indicates that PHA-4 activity is required for Pol II occupancy at 
pharyngeal targets. PHA-4 likely affects the recruitment of Pol II at pharyngeal 
promoters. 
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3.5 Discussion 
3.5.1 Comparison of our finding to recently published Pol II  
studies 
By performing Pol II ChIP-Seq in synchronized early (8E) and mid (bean) 
stage embryos, I identified four different patterns of Pol II occupancy. These 
patterns include a 5’ enriched Pol II occupancy similar to the pattern of poised 
Pol II found in Drosophila embryos and mammalian cells (Nechaev et al., 2010; 
Rahl et al., 2010; Zeitlinger et al., 2007). Recently, several studies of genome 
wide Pol II occupancy in C. elegans have been published, including those by 
modENCODE (Baugh et al., 2009; Zhong et al., 2010; Kruesi et al., 2013). 
Poised Pol II in C. elegans was first reported in L1 larvae arrested by starvation 
(Baugh et al., 2009). Pol II was found to poise at approximately 10% of genes, 
which encoded regulators of growth and development. Further study from Kruesi 
and colleagues isolated short-capped RNA combining global run on sequencing 
(GRO-cap) to map transcriptional engaged Pol II in mixed-stage embryos and L1 
larvae, which further confirmed that starvation can induce Pol II pausing  (Kruesi 
et al., 2013). Many of the genes poised during starvation were activated in 
response to refeeding and subsequently exhibited increased Pol II occupancy 
over the coding regions. When comparing mRNA expression between poised 
and nonpoised genes, the expression of poised genes increased significantly 
during feeding recovery. This study indicates that poised Pol II reflects the 
memory of expression, but perhaps also the priming for future transcription in 
response to feeding. 
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Pol II ChIP-Seq performed in a pha-4::gfp integrated strain from 
modENCODE showed that fewer than 2% of genes exhibited 5’ stalled Pol II in 
mix-staged embryos and L1 larvae under normal feeding conditions. Of these 
stalled genes, around 85% in embryos and half in L1 larvae were bound by PHA-
4, suggesting that PHA-4 may play a role in Pol II stalling (Zhong et al., 2010). In 
addition, over 50% of PHA-4 bound and stalled genes were stalled either in 
embryos or in L1 larvae, which indicates Pol II stalling is specific to stages. PHA-
4 has been shown to bind to 20% of genes in the genome (Zhong et al., 2010) 
and differentially regulates the temporal expression of its targets (Gaudet and 
Mango, 2002; Gaudet et al., 2004). The stalled Pol II at a subset of PHA-4 
targets might reflect the mechanism for controlling the expression of these 
genes. These data suggest that PHA-4 might modulate differential gene 
expression in response to developmental and environmental cues partly through 
regulating Pol II.   
The level of poised Pol II is defined by the ratio of Pol II signal around the 
5’ TSS to the average signal in the gene body. Therefore, precise assignment of 
the TSS of each gene is important to determine the poised genes. As mentioned 
previously, the precise information of TSS for the C. elegans genome was not 
available until three recently published studies (Chen et al., 2013; Saito et al., 
2013; Kruesi et al., 2013). The recently published GRO-cap, which recovered 
nascent transcripts prior to trans-splicing, mapped and assigned TSSs for the C. 
elegans genome (Kruesi et al., 2013). In addition, GRO-Seq also provided the 
direction of each transcript. This information is important for distinguishing read-
	   104	  
through versus the 3’ enriched transcription signals from the adjacent genes 
when examining Pol II poising at gene dense regions. The precise TSS 
assignment of the C. elegans genome was not applied in modENCODE analysis. 
Moreover, GRO-Seq is specific to determine paused genes (which contain 
transcriptional engaged Pol II) in contrast to the Pol II ChIP-Seq performed from 
modENCODE and our study, which detected all forms of Pol II.  These reasons 
might explain why only 0.38% of genes were considered to be paused in mixed-
stage embryos reported from the recent GRO-Seq study (Kruesi et al., 2013) 
when compared to the 2% stalled genes identified from modENCODE (Zhong et 
al., 2010).  
In our research, we employed the TSS information determined by GRO-
cap (Chen et al., 2013; Saito et al., 2013; Kruesi et al., 2013) and found genes 
with poised Pol II that had not been identified previously. One reason for these 
additional genes could be our use of a synchronized population of embryos. It 
has been shown in arrested C. elegans L1 larvae that paused Pol II is quickly 
resolved in response to feeding within an hour and exhibited increased Pol II 
occupancy along gene bodies (Baugh et al., 2009). This observation indicates 
that the regulation of Pol II is dynamic. In mixed-stage embryos, the Pol II signal 
at specific loci is contributed from both early (undifferentiated cells; genes have 
not yet activated) and late (differentiated cells; genes are actively transcribed) 
embryos. With the fast development of C. elegans embryos, late embryos will 
contribute more Pol II signal due to the increase of cell numbers. Therefore, it is 
possible that the 5’ poised Pol II signal in early embryos is masked by elongating 
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Pol II from older embryos. With this concern, our approach provides a temporal 
specificity in capturing Pol II dynamics corresponding to transcriptional activity 
during development.  
 
3.5.2 Following the dynamic Pol II occupancy during  
development reveals different mechanisms of  
gene regulation 
Tracking Pol II occupancy from early (8E), mid- (bean), and late 
(modENCODE mixed late embryos) embryogenesis reveals that Pol II occupancy 
changes dynamically. For example, ceh-22 is highly paused at the 8E stage 
without detectable Pol II within its gene body. At the bean stage, the Pol II signal 
within the gene body had increased, indicating ceh-22 was active for transcription 
(Figure 3.1C). It still exhibited higher levels of Pol II at the 5’ end, suggesting that 
poising was not completely lost at later stages. A subset of mid-stage activated 
pharyngeal targets exhibited similar Pol II dynamics with promoter proximal 
poised Pol II at early embryonic stages and less at later embryogenesis (Table 
A.2). More interestingly, poised PHA-4 targets indentified from our research 
showed stage specificity in which 12% and 35% of poised pharyngeal genes 
were only poised at 8E and bean stages, respectively (Gaudet and Mango, 2002; 
Gaudet et al., 2004). Pharyngeal genes specifically poised at the 8E stage show 
significant increase of mRNA expression after the bean stage (Levin et al., 2012). 
In addition, two pharyngeal genes specifically poised at the bean stage, T04B8.2 
and cdc-25.2, are highly expressed during early embryogenesis, and their 
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expression is reduced after the 8E stage (Table 3.2) (Levin et al., 2012). This 
observation agrees with the previous reports that poised Pol II is associated with 
both the preparation of gene activation and the memory of gene expression 
(Baugh et al., 2009; Gaertner et al., 2012). These data support that Pol II poising 
might be a mechanism to control temporal pharyngeal gene expression.  
Why might C. elegans embryos require poised Pol II? Embryogenesis in 
C. elegans is rapid with cell divisions occurring at periods less than an hour at 
early embryonic stages. Having Pol II poised at the 5’ end of genes during 
embryogenesis might provide a means to switch gene expression on and off to 
execute developmental decisions.  
 
3.5.3 PHA-4 activity is required for Pol II recruitment at  
pharyngeal promoters 
Eukaryotic gene expression can be regulated at the level of Pol II 
recruitment or alternatively by the release of paused Pol II for productive 
elongation. To understand how PHA-4 regulates pharyngeal gene expression, I 
analyzed the Pol II occupancy at poised pharyngeal promoters in pha-4 mutant 
embryos. If PHA-4 regulates pharyngeal expression by Pol II recruitment, I 
expected a decrease in Pol II occupancy at promoter proximal regions when 
PHA-4 activity was eliminated. Examining Pol II at poised pharyngeal promoters 
ceh-22 and T06D8.3, in pha-4 mutant embryos, I found a significant decrease in 
Pol II occupancy at the TSS (Figure 3.2C and 3.3B). These data imply that PHA-
4 activity affects the recruitment of Pol II at promoter proximal regions. I note that 
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this does not rule out an additional role for PHA-4 in the release of Pol II. There is 
precedence for this idea since in yeast the related fkh1 factor is thought to 
regulate transcriptional elongation by recruiting p-TEFb (Morillon et al., 2003). 
Other selector genes function at multiple stages of the transcription cycle. For 
example, MyoD controls over 300 myogenic target genes both by facilitating PIC 
assembly at promoters and by recruiting p-TEFb to phosphorylate Pol II and 
promote transcriptional elongation (Deato et al., 2008; Giacinti et al., 2006). PHA-
4 functions as a pioneer factor that binds to pharyngeal targets long before gene 
activation to induce chromatin decompaction (Fakhouri et al., 2010; Friedman 
and Kaestner, 2006; Zaret et al., 2008). The open chromatin created after PHA-4 
binding to its targets may facilitate Pol II assembly at promoter proximal regions 
or vice versa.  
Growing pha-4(ts) at the restrictive temperature resulted in eliminating 
pha-4 expression and pharyngeal gene expression (Figure 2.3E). Loss of PHA-4 
activity early in development makes it difficult to examine PHA-4 function at both 
the recruitment and the release of Pol II. A follow-up experiment will be to 
examine Pol II dynamics at pharyngeal genes in the embryos undergoing a 
temporal increase and decrease in PHA-4 activity by heat shock and RNAi at 
different stages. As shown in Chapter 2, reduced PHA-4 level by RNAi resulted 
in delayed Pceh-22::GFP expression. What is the pattern of Pol II occupancy at 
ceh-22 when PHA-4 level is low but can still activate ceh-22 expression? These 
experiments will provide insights of PHA-4 regulated Pol II occupancy during 
transcriptional cycles. 
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In summary, my study provides a temporal resolution of Pol II occupancy 
during C. elegans embryogenesis. Our finding also gives a taste of how organ-
specific poised genes were set up by a selector gene. How PHA-4 primes gene 
expression by regulating Pol II in a temporal manner and how genes are poised 
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CHAPTER 4 
 
SUMMARY, CONCLUSIONS, AND FUTURE DIRECTIONS 
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4.1 Summary 
 The study described in this dissertation explored the molecular 
mechanisms of differential gene expression regulated by selector genes. 
Selector genes play an important role in specifying biological identity of cells, 
tissues, and organs during development, and their functions are often conserved 
among different organisms. The overview of Chapter 1 highlighted the ability of 
selector genes to orchestrate comprehensive transcriptional programs to fulfill 
the requirements for building specific functional structures, such as the pharynx 
in C. elegans. Molecular mechanisms of differential gene expression were 
reviewed and compared among different selector genes. Hierarchal activation of 
gene expression cascade is utilized to regulate the development of tissues and 
organs with less complexity, such as the intestine in C. elegans, which is 
composed of single cell type. Combinatorial regulation by selector genes and 
other transcription factors are incorporated into feed-forward circuits that lead to 
temporal and spatial gene expression patterns for other organs and tissues. This 
mechanism is a common strategy employed by many selector genes, including 
MyoD and PHA-4/FoxA. Here, I specifically focused on PHA-4/FoxA-regulated 
temporal pharyngeal gene expression. According to previously proposed models, 
PHA-4 mediates the onset of gene expression through binding affinity to its 
targets coupled to combinatorial regulation (Gaudet and Mango, 2002; Gaudet et 
al., 2004). Inputs from both PHA-4 affinity sites and temporal elements contribute 
to precisely time pharyngeal gene expression. 
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This thesis also considered the events downstream of selector genes, 
specifically the role of Pol II poising in regulating differential gene expression 
during development. Pol II poising is pervasive in flies, mice, and human cells but 
rare in worms. The similarity and difference of Pol II regulation between 
Drosophila and C. elegans was discussed to better understand Pol II pausing in 
regulating differential gene expression.  
In Chapter 2, I concentrated on the PHA-4 affinity model for temporal 
control of pharyngeal expression. The affinity model predicts that pharyngeal 
expression should be sensitive to the level of PHA-4, including overexpression of 
PHA-4. This idea has never been tested. I tested the affinity model by 
investigating pharyngeal expression patterns with narrow (2–3-fold) or drastic 
(>10 fold) changes of PHA-4 levels. Dramatically increased or decreased PHA-4 
levels affected the pharyngeal expression patterns. This result suggests that 
pharyngeal expression is sensitive to PHA-4 concentration but can maintain 
robust expression within a range of PHA-4 level fluctuation. This is in contrast to 
mammals, which are sensitive to a two-fold reduction in FoxA2 activity (Ang and 
Rossant, 1994; Kittappa et al., 2007; Weinstein et al., 1994). I further explored 
binding site affinity by examining PHA-4 binding to different affinity targets in 
vivo, using NSA and ChIP. This analysis revealed that PHA-4 bound to both high 
and low affinity targets hours before active transcription. In addition, the level of 
PHA-4 occupancy was affected by the affinity of PHA-4 binding sites within the 
target promoters. However, the effect of affinity on the level of PHA-4 binding 
was variable among different pharyngeal promoters, as we observed a greater 
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change of PHA-4 binding when the binding site affinity was altered within the 
M05B5.2 promoter but not at the ceh-22. The drastic decrease in PHA-4 binding 
at the M05B5.2 promoter with a down mutation of PHA-4 binding site is 
correlated with delayed onset of the GFP reporter driven by the same promoter 
construct. These results indicate that binding site affinity plays a role in regulating 
the level of PHA-4 occupancy at target promoters to modulate the onset of gene 
expression. 
Sequence-specific transcription factors modulate specific transcriptional 
programs through directly or indirectly regulating RNA Pol II at target genes. As 
studies of poised Pol II in flies and mammals reveal its important role in 
regulating differential gene expression, Pol II poising in worms is still largely 
unknown. In Chapter 3, I examined dynamic Pol II occupancy during 
embryogenesis by performing Pol II ChIP-Seq in synchronized early (8E) and 
mid (bean) embryos. I identified genes that exhibited different patterns of Pol II 
occupancy that reflected their transcriptional status. Moreover, 4% and 7% of 
genes, including a subset of pharyngeal genes, showed promoter proximal 
poised Pol II at the 8E and bean stages, respectively, which suggests that Pol II 
poising is stage specific in C. elegans embryos. To test the idea that PHA-4/FoxA 
functions as a pioneer factor might be involved in establishing poised Pol II, I 
examined Pol II occupancy at poised pharyngeal genes in pha-4(ts) mutant 
embryos. Promoter occupancy of Pol II at poised pharyngeal genes was greatly 
decreased when PHA-4 was eliminated. This result indicates that PHA-4 activity 
is required to load Pol II at a subset of pharyngeal genes. I hypothesize that 
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PHA-4 primes gene activation partly through affecting temporal Pol II occupancy 
at pharyngeal promoters. This is exciting because I am not aware of papers 
showing a link between a selector gene and poised Pol II. Perhaps the 
decompaction of chromatin observed for FoxA factors relates to loading of Pol II. 
However, at this point we do not know if chromatin opening facilitates Pol II 
loading or if loading of Pol II destabilizes a nucleosome. This question will be the 
subject of future experiments.  
 
4.2 Conclusions 
Binding affinity between transcription factors and their recognition 
consensus sequences is used in many developmental contexts to regulate 
differential gene expression (Gaudet and Mango, 2002; Hollenhorst et al., 2009; 
Lam et al., 2008; Stathopoulos and Levine, 2004). Our study of PHA-4 affinity 
model in temporal gene regulation provides insights to understand the basic 
molecular mechanisms in regulating and maintaining a precise transcriptional 
program. First, PHA-4 binds to both high and low affinity targets prior to active 
transcription at early embryonic stages. Second, the binding site affinity impacted 
the level of PHA-4 occupancy at its target promoters. Third, the effect of affinity 
on PHA-4 binding was most pronounced at early embryonic stages. Fourth, PHA-
4 levels normally increase during embryogenesis, and alterations in PHA-4 levels 
affected the onset of pharyngeal expression, especially at early embryonic 
stages from the 2E to 8E stages. These observations were reminiscent of the 
open chromatin configuration associated with developmental plasticity in early 
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embryos (Meister et al., 2011; Meshorer and Misteli, 2006; Yuzyuk et al., 2009). I 
hypothesize that the decompacted and accessible chromatin at early embryonic 
stages (Yuzyuk et al., 2009) permits PHA-4 binding to targets with different 
affinity sites even when PHA-4 expression level is still low at early stages. 
However, low affinity sites, coupled to low levels of PHA-4 at early stages, lead to 
low occupancy. Therefore, the affinity effect on the level of PHA-4 binding is 
emphasized at earlier stages compared to later stages, which explains the 
advanced onset of pharyngeal activation when PHA-4 was dramatically 
increased at early embryonic stages but not later stages. These data explore 
how PHA-4/FoxA as a pioneer factor broadly regulates pharyngeal gene 
expression through binding affinity with its targets. 
Pol II poising at developmental regulators provides a strategy to set up 
developmental programs in the early Drosophila embryos (Chopra et al., 2011; 
Zeitlinger et al., 2007), but much less is known about the role of poising in C. 
elegans where poising is less pervasive. The Pol II ChIP-Seq study described in 
Chapter 3 provided evidence of poised Pol II in early C. elegans embryos. My 
study is similar to the previously characterized Pol II poising in Drosophila 
embryos where poised Pol II is specific to embryonic stages and dynamically 
regulated over time (Gaertner et al., 2012). Similarly, I observe loci with poised 
Pol II at the 8E stage but not the bean stage and vice versa. Other loci show 
poised Pol II both early and late.  
Focusing on a subset of pharyngeal genes, I demonstrated that PHA-
4/FoxA was required for Pol II occupancy at poised pharyngeal promoters. This 
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result suggests that other Fox factors might function similarly to mediate gene 
expression through regulation of Pol II dynamics and raises the question whether 
other selector genes also regulate poising. Overall, my work delineated the role 
of PHA-4 function in establishing a precise pharyngeal transcription during 
pharynx development.     
 
4.3 Future directions 
The analysis of PHA-4 binding to individual targets by NSA and ChIP 
provides a framework for studying transcriptional regulation. To gain a 
comprehensive understanding of PHA-4 orchestrated foregut formation, it would 
be insightful to examine the genome-wide temporal PHA-4 binding patterns at 
endogenous loci. I attempted this analysis but encountered difficulties with the 
antibodies used in ChIP. A genome-wide study of temporal PHA-4 binding could 
solidify and expand our understanding about binding site affinity involved in 
global gene regulation during organogenesis.  
How does the level of PHA-4 occupancy at different affinity sites translate 
to expression onset? A possible mechanism is through controlling the recruitment 
of downstream factors required for pharyngeal activation, including cofactors, 
other transcription factors, and RNA Pol II. Our NSA studies showed that PHA-4 
binding to its targets resulted in decompaction of the arrays (Fakhouri et al., 
2010) and loading of the histone variant H2A.Z (Updike and Mango, 2006). 
Further studies combining PHA-4 binding affinity illustrated in Chapter 2 
demonstrated that the level of PHA-4 occupancy was correlated with the 
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decompacted array sizes. Taking advantage of the temporal and single cell 
resolution of the NSA, we could study the affinity effect on the timing of 
downstream recruitment of other factors. For example, one could generate arrays 
carrying the myo-2 promoter with different PHA-4 affinity sites and examine the 
patterns of CEH-22 binding.  
One intriguing result from the NSA is that the PHA-4 affinity effect was 
different for M05B5.2 and ceh-22. I observed a dramatic effect on the level of 
PHA-4 binding when the PHA-4 affinity site was mutated in the M05B5.2 
promoter but the effect was minor for the ceh-22 promoter. Inspired by the Pol II 
study in Chapter 3, one possible explanation is the different patterns of Pol II 
occupancy at the M05B5.2 and ceh-22 promoters. Pol II was poised at ceh-22 
but not at M05B5.2 from the 8E stage. In Drosophila, poised Pol Il can function to 
maintain an open chromatin configuration (Gilchrist et al., 2010; Gilchrist et al., 
2008). Perhaps, poised Pol II at the ceh-22 promoter promotes chromatin 
opening in combination with PHA-4. This idea could be tested by examining the 
level of Ser5p Pol II (the transcriptional engaged Pol II) on the arrays carrying 
either M05B5.2 or ceh-22 promoter. From another angle, we could also examine 
the nucleosome profiles at endogenous M05B5.2 and ceh-22 loci. The dynamic 
genome-wide nucleosome profile during C. elegans embryogenesis is an on-
going project being carried out by Huei-Mei Chen, a talented postdoctoral fellow 
in our lab. Her study will explore the connection between chromatin dynamics, 
PHA-4, and transcriptional regulation. 
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An appealing finding from the Pol II study is that PHA-4 might play a role 
in establishing poised Pol II at pharyngeal genes. Perhaps this is how PHA-4 
functions as a pioneer transcription factor. We have tested the requirement of 
PHA-4 activity on Pol II occupancy at several poised pharyngeal genes. Further 
Pol II ChIP-Seq in pha-4(ts) embryos will confirm this argument. 
Losing 5’ poised Pol II at a subset of pharyngeal genes that is caused by 
the lack of PHA-4 activity during early embryogenesis makes it hard to interpret 
whether PHA-4 is also involved in regulating Pol II after its recruitment at 
promoters. We have shown that the perturbation of PHA-4 expression to 
increase or decrease PHA-4 levels resulted in shifting the temporal pharyngeal 
activation, including the ceh-22, which exhibited poised Pol II. Using ceh-22 as 
an example to study PHA-4 and the dynamic changes of Pol II occupancy would 
further explore the mechanisms of PHA-4 controlled temporal gene expression.   	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Sequences of primers used for ChIP-qPCR and RT-qPCR. 
 
Primer name Sequences Note 
taf-1 pro-F TTTTTCAGCGAAATGATTGTAAA  
taf-1 pro-R CAACCAACTCCGGAAAAACTAA  
eft-3 pro-F AGCGTTTTTCCTGTTCTCACTGTTT  
eft-3 pro-R GAGTGCGGACGGTAGAGAGAATAAA  
ceh-22 pro-F GCTTTCGGAGCATTAACCTAGA  
ceh-22 pro-R TGAGCATCTCGGCTAACAATAA  
ceh-22 TSS-F AGCAACATGGATTGTCTACAAGTG  
ceh-22 TSS-R TACTTGTTATGAAGTGCCGATTGT  
ceh-22 intron1-F TGAAACGGGATGAAAATATCCT  
ceh-22 intron1-R TTTTCTTTGAAAATGGGGAGAA  




ceh-22 ex6-F AAGTGCCAATTCAGGATACCTACC  
ceh-22 ex6-R GTCATGTAGGAAGAAGCTGCTGAA  
SRW-99 pro-F TCAAAATGTTCCCACGTCTATAAAACTTAC  
SRW-99 pro-R AAAAAGAGCATTTTGCAATACGTTAGAG  
T06D8.3 pro-F CTAGTTATACCGTCCGCCTACCTGT  
T06D8.3 pro-R ATGCTTAACTGTTCAGGGGGAGA  
T06D8.3 TSS-F GCAACGACATGTCCGTGCCAGCTTCG  
T06D8.3 TSS-R ATGTAAAGAAATCTGTCGCTTCGAG  
T06D8.3 in2-F GGTACTACTTGAGGTAAGCCTTTGACA  
T06D8.3 in2-R CTCGCCGAGCAAATCATAGTACAAAC  
T06D8.3 ex3-F TTTTGTCACTATCGCTGAGGCTTAC  
T06D8.3 ex3-R CATCTCGACAGTAAAATACCCGATG  
T06D8.3 ex8-F AATCCTTCCATAGAACCATCAGTCC  
T06D8.3 ex8-R ATGCACCTAGTACCGATATCCATCA  
myo-2 pro-F ATGGCAGGAAGAGCACTTTG  
myo-2 pro-R ATGCAGAGAGGCAGACATCC  
myo-2 ex4-F GGAGAATCTGGTGCAGGAAA  
myo-2 ex4-R GCTCCGAAGGTCTCTTGTTG  
myo-2 ex8-F CACCAACAAACCATCGACAG 
myo-2 ex8-R CGGCTTCCAACTTCTTCTTG 
Used for both 
ChIP-qPCR 
and RT-qPCR 
pha-4_qPCR_Fwd CGGCTGTTAATCACAGTCAACCTACTTCAG  
pha-4_qPCR_Rev CCGAACTGTAGAGGTAAGGAGACGC  
ceh-22 ex1-ex2 F CTTCATAACAAACTCGAAGCTAAATGGG  
ceh-22 ex2-ex3 R GGAGTAGCAGAATATCCTGCAAGTAATGG  
SRW-99 ex1-ex2 F TTGTCAATGACATTGCCAATTACGCGC  





Table A.1 continued. 
 










myo-2 AS-ex12-R GGGAAAGTTGGACGGTTCTGTA  
myo-2 S-ex5-F GTTTGGCAAGTAATCGGAGAAG  
myo-2 S-in4-R CGAATGTTTGACCTGTATATAT  
myo-2 S-ex12-F ACAGCTTCCTCGAGTTGCTTCT  













Encoded protein Expression 
(Levin et al. 2012) 
Poised at 
the 8E 
    
alp-1 219  α-actin associated 
protein 
From the bean 
stage 
F30H5.3 919  unknown From the bean 
stage 
     
Poised at 
the 8E and 
bean 
    
Inx-3 84 276 innexin protein Constantly express  
ceh-22 90 307 NKX homeobox 
transcription factor 
From the bean 
stage 
ain-1 745 655 GW182 family 
protein, involve in 
miRNA-mediated 
gene silencing 
From the pre-bean 
stage 
D1054.9 201 814 unknown From the comma 
stage 
ces-2 455 907 bZIP transcription 
factor 
From the pre- 
bean stage 





Table A.2 continued. 
 
tbx-2 54 756 T-box transcription 
factor 
From the 12E 
stage 
fbxc-23 576 737 F-box c protein From the pre- 
bean stage 
inos-1 1059 1561 myo-inositol-1-
phosphate synthase 
Constantly express 
     
Poised at 
the bean 
    






From the comma 
stage 
T04B8.2  263 F-box protein Express early from 
the 2E, expression 
is dropped at the 
comma stage 
cdc-25.2  593 Cdc25 phosphatase Express early from 
the 2E and 
expression is 
decreased after 
the 8E  
K10D3.4  615 unknown From the bean 
stage 
T28B8.1  1482 unknown From the bean 
stage 
T09B4.5  1634 unknown From the bean 
stage 
 
 
 	  
